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ABSTRACT 
 
 Economic losses in the nursery phase of pork production can largely be attributed 
to the underdeveloped gastrointestinal tract (GIT) and immune system of weaned pigs, 
which greatly increases their susceptibility to potential pathogens. Enterotoxigenic 
Escherichia coli (ETEC) is a common enteric pathogen that results in secretory diarrhea 
and leads to reductions in growth performance and increases in mortality, morbidity, and 
treatment costs. Vaccinations and antibiotics have traditionally been used as means of 
prevent or mitigating ETEC infections; however, with the increase in antibiotic resistant 
pathogens and pressure from the consumer population, pork producers are in need of 
alternative strategies. Dietary inclusion of direct-fed microbials (DFM) have been 
proposed as a potential dietary strategy to prevent or mitigate the negative effects 
associated with weaning and ETEC infections due to their suggested ability to exert 
beneficial effects on the host’s GIT, immune system, and microbial population. 
Nonetheless, having an understanding of how disease physiologically impacts the pig is 
essential to developing effective alternative dietary technologies to prevent or mitigate 
disease. Therefore, the objectives of this thesis were to characterize the impact of an ETEC 
challenge in weaned pigs on growth, intestinal function, immune response, and mucosal 
microbiota, and to evaluate the potential beneficial effects of Bacillus-based DFMs under 
normal physiological and ETEC challenge conditions.  
To achieve our objective, two experiments were conducted. The results of 
Experiment 1 (Chapter 2) revealed that Bacillus-based DFMs did not affect body weight 
or growth performance of healthy nursery pigs housed in a commercial-like environment 
compared to the control diet, which may be a result of contrasting effects of the DFM 
 ix  
products and dietary ingredients, such as zinc oxide. Experiment 2 (Chapters 3 and 4) 
investigated the impact of an F18 ETEC challenge on growth performance, intestinal 
function, immune response, and mucosal microbiota of weaned pigs, as well as evaluated 
the potential protective effects of two Bacillus-based DFMs (DFM1 And DFM2). The 
ETEC challenge increased fecal scores, reduced rectal temperature, impaired intestinal 
barrier integrity, altered immune response, resulting in reduced growth performance during 
10-d post-challenge period. The ETEC challenge also induced dysbiosis in the mucosa-
associated microbiota by increasing the abundance of potentially pathogenic bacteria and 
reducing the abundance of beneficial microbes. Our results suggest that the 
supplementation of DFM2 may potentially alleviate negative impacts of an ETEC 
challenge by improving intestinal barrier integrity and reducing bacterial pathogen load in 









Weaning is one of the most significant events in a pig’s life and represents major 
challenges in developing their intestinal epithelial barrier and immune system. Abrupt 
removal from the sow, transportation and handling, changes in diet and social and physical 
environment, and exposure to new pathogens all contribute to poor performance and 
increased mortality following weaning. The gastrointestinal tract (GIT) provides a physical 
and immunological barrier for piglets subjected to pathogens. This barrier is a complex but 
elegant system composed of defense mechanisms provided by epithelial cells and the 
mucosal immune system acting to regulate normal GIT barrier function, immunological 
responses, and homeostasis.  
Pathogens, such as enterotoxigenic Escherichia coli (ETEC), breakdown these 
components of GIT function causing decreases in feed intake and growth and reducing 
overall animal health and survivability. Inflammatory responses and interactions between 
the GIT mucosa and lymphoid tissues are essential in the host defense against ETEC.  
Concerns regarding antimicrobial resistance and consumer demand has led to 
reduced antibiotic use in swine production. Consequently, alternative non-antibiotic 
products to mitigate ETEC are currently being investigated; however, in order to develop 
such strategies to mitigate this disease, a concrete understanding of ETEC’s mechanism of 
action is required. The objective of this review is to discuss the impact of post-weaning 





in nursery pigs. The utilization of non-antibiotic feed additives, especially direct fed 
microbials (DFMs), in the prevention and mitigation of post-weaning diarrhea will also be 
reviewed.  
 
Gastrointestinal tract function 
The gastrointestinal tract is responsible for digestion and absorption of many 
nutrients, including water, lipids, proteins, carbohydrates, vitamins, and minerals. In 
addition, the GIT serves as the largest immune organ in the body and provides a barrier 
between the lumen and systemic circulation. Maintaining a healthy GIT is essential for the 
productivity and longevity of an animal. The term ‘gut health’ has been increasingly used 
across both human and animal health industries, and is an area of study that has gained 
significant interest around the world. This term encompasses a wide variety of meanings, 
making it difficult to establish a consensus definition. Gut health comprises multiple 
physiological and functional properties and their interactions among each other, including, 
but not limited to, intestinal structure and integrity, digestion and absorption of nutrients, 
mucosal immunity, and a stable microbial population (Moeser et al., 2017; Pluske et al., 
2018).  
General description 
The GIT barrier is a multi-layer system comprised of both physical and chemical 
defense mechanisms to prevent and alleviate pathogen infiltration. A single layer of 
selectively permeable intestinal epithelial cells (IECs) line the GIT and serves as the 
primary border between the pig and its external environment. The maintenance of the IEC 





stimulation. Both the apical and basolateral membranes of the intestinal epithelium are 
home to several receptors, enzymes, transporters, channels, and pumps that are essential to 
facilitating the breakdown and uptake of important nutrients needed by the pig. 
Furthermore, the GIT also has a large excretory function and is responsible for preventing 
absorption of unneeded or harmful substances. 
Defense mechanisms 
Preserving the physical barrier and intestinal integrity of the GIT is largely 
dependent upon junction complexes connecting the enterocytes of the intestinal epithelium. 
These complexes are comprised of multiple intercellular membrane proteins including tight 
junctions (TJ), adhesion junctions, desmosomes, and the gap junction. In particular, 
paracellular permeability between enterocytes is largely maintained by interactions 
between the TJ proteins: claudins (CLDN), occludin (OCLN), and zonula occludens (ZO) 
(Tsukita et al., 2001). These proteins play a significant role in preventing harmful bacteria 
and their products (e.g. endotoxin) from translocating across the intestine and activating an 
immune response (Mukiza et al., 2013).  
The mucosal immune system is essential in balancing the competing demands of 
pathogenic antigens derived from the environment and harmless antigens, including 
nutrients and commensal organisms. Secretory immunoglobulin A (sIgA) is an anti-
inflammatory compound that is the predominant class of antibody found in the mucosal 
immune system and provides important humoral protection against pathogenic infection in 
the GIT. sIgA is the first line of barrier defense by the intestinal mucosa and has an 
important role in maintaining homeostasis of the host’s commensal bacteria. In the event 





epithelium and binds via their carbohydrate component. Once bound, it aims to prevent 
bacterial adherence to the intestinal epithelium. If the bacteria are able to penetrate the 
barrier, sIgA has the ability to neutralize the lipopolysaccharide component of the gram-
negative bacteria within the endosome of the epithelial cells (Cerutti and Rescigno, 2008; 
Corthesy, 2013).  
Microbiota and microbial metabolites 
A substantial and diverse population of bacteria comprise the pig’s GIT, all of 
which have a key role in maintaining an animal’s overall health. As culture-independent 
analysis of intestinal microbiota has progressed with the development of high-throughput 
sequencing technology, including 16s rRNA sequencing, research has shown that the gut 
microbiota impacts multiple physiological traits in the host (Camarinha-Silva et al., 2017; 
Leulier et al., 2017; Han et al., 2018). An estimated 100 trillion bacterial cells inhabit the 
mammalian gut and support host health through beneficial metabolite production, such as 
short-chain fatty acids (SCFA), inhibition of pathogen colonization, and immune system 
preservation (Holman et al., 2017). Although it is difficult to define a healthy gut 
microbiota, it is important to note that several species have multiple strains, some of which 
are commensal and others pathogenic. The balance of the microbial ecosystem is achieved 
through commensal, neutral, antagonistic, and symbiotic relationships between bacterial 
species (Boon et al., 2014). 
It is well established that diet largely influences gut microbe composition, as it is 
the main source of growth substrate (Frese et al, 2015; Heinritz et al., 2016). The microbes 
are also very important for digesting dietary compounds left undegraded by endogenous 





undigested carbohydrates results in the production of SCFAs, which are rapidly absorbed 
and utilized as an energy source for the enterocytes (den Besten et al., 2013). Gut microbes 
can also utilize nitrogen from dietary compounds. This mainly occurs in the large intestine, 
where many bacteria utilize peptides and amino acids as carbon, nitrogen, and energy 
sources (Dai et al., 2010).  
Given that diet plays an essential role in shaping the gut microbial population, the 
relationship between age and intestinal microbiota is an important consideration, as growth 
stage and dietary composition are directly associated with one another. Stress during the 
weaning period results in substantial disruptions to the GIT microbial environment 
(Konstantinov et al., 2006), partly due to the introduction of cereal-based diets and 
reductions in feed and water intake (Mach et al., 2015). This increases the pig’s 
susceptibility to pathogenic infections from organisms such as Salmonella, Escherichia 
coli, and Clostridia. Mucin production by intestinal goblet cells is critical to prevent 
pathogen adherence and penetration. Beneficial microbes, such as Lactobacillus, improve 
mucin production and are a key factor in disease prevention (Fouhse et al., 2016). It has 
also been shown that increases in Prevotella are positively correlated with sIgA 
concentrations and improved growth performance (Mach et al., 2015). Other factors 
including genetics, environment, and health status have been shown to influence changes 
across microbial communities. Kubasova et al. (2018) evaluated the fecal microbial 
composition of high or low residual feed intake (HRFI and LRFI) pig lines via 16s rRNA 
sequencing and observed a greater abundance of Megasphaera and Lactobacillus in HRFI 
pigs. Additionally, microbial adaptation to new diets following weaning was slower in 





et al. (2014) reported differences in fecal microbial communities of pigs housed in either 
good or poor hygiene conditions.  
 
Post-weaning diarrhea 
Despite numerous vaccines and dietary interventions, post-weaning diarrhea 
(PWD) resulting from E. coli infection continues to have a considerable negative impact 
on global swine production. Increases in mortality, morbidity, and treatment costs coupled 
with decreases in growth performance cause significant economic losses for pork producers 
and the industry (Fairbrother and Gyles, 2012). Post-weaning diarrhea commonly occurs 
between 4 and 14 days following weaning. Susceptibility to PWD is intensified by multi-
factorial stressors at weaning, including sudden changes in environment, social 
interactions, and diet, as well as immature intestinal and immune system development in 
newly weaned pigs (Campbell et al., 2013; Heo et al., 2013). 
While there are many classifications of E. coli, the most common is ETEC (Zhang 
et al., 2007). Additionally, ETEC carries the greatest economic importance among 
pathogenic E. coli in pigs (Gyles and Fairbrother 2010). Environmental ETEC enters the 
pig GIT orally. Several factors including poor hygiene, insufficient disinfection, low 
environmental temperature, and excessive air flow promote development of diarrhea and 
accumulation of ETEC in the environment (Gyles and Fairbrother 2010). 
Pathogenesis 
Fimbrial adhesins and enterotoxins are the major virulence factors of ETEC 
induced diarrhea (Zhang et al., 2007). ETEC adhere to the small intestinal mucosa and 





that facilitate bacterial attachment to the host’s receptors. The fimbrial adhesins most 
commonly associated with PWD in pigs are F4 (K88) and F18 (Zhang et al., 2007). 
Susceptibility to ETEC is determined by expression of fimbrial adhesin binding 
receptors in the pig small intestine. (Frydendahl et al., 2003; Roubos-van den Hil et al., 
2017). F4 receptor expression is present both in neonatal and weaned pigs, whereas F18 
receptors, whose expression are controlled by the α (1,2)-fucosyltransferase gene (FUT1), 
are absent in neonatal piglets and not fully expressed until approximately 3 weeks of age. 
(Fairbrother et al., 2005; Coddens et al., 2007). Following adhesion and colonization of the 
small intestine, secreted enterotoxins can be translocated to the small intestine. 
Enterotoxins disrupt water and electrolyte balance in the small intestine resulting in 
increased secretion of chloride and carbonate ions, inhibition of sodium and water 
absorption, and eventually secretory diarrhea. Continual secretion leads to dehydration, 
metabolic acidosis, and death. ETEC strains produce several enterotoxins, including heat 
labile, heat stable, and enteroaggregative heat-stable enterotoxins (Sun and Kim, 2017). 
Impact of post-weaning diarrhea in pigs 
Experimental induction of PWD has been achieved through ETEC challenge 
models in order to evaluate immunological, intestinal barrier, and growth performance 
responses in weaned pigs. Challenges can induce either subclinical or clinical symptoms 
of ETEC infection. Pigs with subclinical expression of disease lack visual symptoms, such 
as watery diarrhea, but still have an immune system response and often reductions in 
growth performance (Martin et al., 1987). 
In addition to clinical symptoms, ETEC infections in pigs are known to increase 





redistribution and dissociation of diarrhea (Berkes et al., 2003; Roselli et al., 2007). ETEC 
enterotoxins can stimulate secretion of pro-inflammatory cytokines (TNF-, IL-1, etc.), 
which triggers phosphorylation of the myosin light chain, resulting in contraction and 
opening of tight junction proteins (Gao et al., 2013; Turner et al., 1997). In ETEC 
challenged pigs, decreases in ileal claudin-1, claudin-2, occludin, and ZO-1 TJ proteins 
have been reported (Ewaschuk et al., 2011; Gao et al., 2013; Li et al, 2019). Ewaschuk et 
al. (2011) also observed an increase in mannitol flux across the jejunum, further validating 
the increase in intestinal permeability following an ETEC infection.   
When the tight junctions are disrupted, paracellular transport of luminal contents 
and pathogenic material into circulation can increase, activating an immune response and 
intestinal inflammation through TLR4 and CD14 binding (Guo et al., 2013). TLR4 and 
CD14 are co-receptors of LPS, a powerful innate immune system stimulus produced by 
gram-negative bacteria (Alexander and Rietschel, 2001). This is in agreement with Li et 
al., (2019), who reported an increase in ileal TLR4 and CD14 mRNA in ETEC challenged 
pigs compared to a non-challenged control, indicating an immune system activation 
followed by an ETEC challenge. Studies have also described changes in localized immune 
responses in the small intestine due to an ETEC challenge, as supported by increased ileal 
macrophages and neutrophils (Liu et al., 2013), an upregulation in cytokines IL-1B, IL-8, 
IL-17A, TNF-, and IFN- mRNA (Loos et al., 2012; Liu et al., 2014; Li et al., 2019), and 
increased sIgA (Gao et al., 2013, Zhang et al., 2013). Previous research has shown that an 
ETEC challenge also results in systemic immune system activation. Liu et al. (2013) 
reported increased levels of serum TNF- and haptoglobin and decreased white blood cell 





are in agreement with Sugiharto et al. (2014), who found elevated plasma IgA, neutrophils, 
and lymphocytes following an F18 ETEC challenge.  
Intestinal morphology is a key marker that reflects GIT development. ETEC 
attachment to the small intestine without destruction of the microvilli is critical for 
pathogen elaboration; however, research evaluating the influence of ETEC on intestinal 
structure in pigs is inconsistent. Villus atrophy and reductions in villus height:crypt depth 
in the small intestine following an ETEC challenge have been described (Yi et al., 2005; 
Gao et al., 2013), while others reported no association between an ETEC challenge and 
changes in intestinal morphology (Liu et al., 2013). Changes in villus height and crypt 
depth are often correlated with digestive and absorptive capacities of the GIT (Pluske et 
al., 1997; Tsukahara et al., 2012). While the effects of weaning on digestion and absorption 
have been well described (Montagne et al., 2007; Wijtten et al., 2011), there is a paucity of 
literature describing the impact of an ETEC challenge in pigs on these functions.  
Pathogenic bacterial infections cause proliferation of harmful bacteria, resulting in 
dysbiosis of the intestinal microbiota (Burrough et al., 2017; Gresse et al, 2017). Post-
weaning diarrhea is often characterized by a decline in lactic acid-producing bacteria 
(Lactobacillus spp.) and the increase in clostridia and pathogenic E. coli in the GIT 
(Konstantinov et al., 2006); however, a greater understanding of microbiota changes 
following a direct ETEC challenge in weaned pigs is needed. The continued development 
of new technologies, such as Next-Generation Sequencing (NGS), offers means to 
investigate microbial communities and their interactions with the host immune system, 






Alternatives to the use of sub-therapeutic antibiotics 
As our understanding of potential adverse consequences of including antibiotics in 
pig diets has increased, there is a growing interest in antibiotic-free and reduced antibiotic 
pork production, particularly in weaned pigs. Removal of antibiotics from newly weaned 
pigs has greater negative implications compared to other production stages due to large 
growth performance reductions, high mortalities, and increased disease incidence (Hao et 
al., 2014), all resulting from the stressors associated with weaning, as previously discussed. 
Historically, vaccines and antibiotics have been utilized to prevent and control ETEC 
infections in commercial nurseries. ETEC outbreaks are still present worldwide, and with 
increasing limitations on antibiotic use in pork production, concerns of antimicrobial 
resistance, as well as consumer demand to reduce antibiotic use, alternatives to these 
treatments are necessary. Nutritional intervention is largely being investigated as a means 
of preventing and/or mitigating ETEC. Commonly investigated feed additives include 
direct-fed microbials, acidifiers, enzymes, plant extracts, fiber, prebiotics, and 
antimicrobial peptides. (Pettigrew, 2006; Stein and Kil 2006; Kil and Stein, 2010). The 
objective of these feed additives in nursery pigs is to prevent or mitigate post-weaning 
diarrhea and subsequent economic losses. This objective is often met by developing the 
pigs’ ability to prevent colonization of pathogenic bacteria via alteration of the gut 
microbiota and environment, improved immunological response, or enhanced intestinal 
barrier function. The strengths, weaknesses, and potential modes of action of these 
alternative feed additives have been previously reviewed. (Thacker, 2013; Liu et al., 2018). 







Direct-fed microbials, often referred to as probiotics, have been utilized in both 
human nutrition and livestock production for many years. The Food and Drug 
Administration implemented that the label “probiotic” only be applied to microbial 
products for human use; consequently, the label “DFM” is utilized in the U.S. feed 
industry. Direct-fed microbials are defined as products that “contain live naturally 
occurring microorganisms” (FDA, 2015). Bacterial strains including Bacillus, 
Lactobacillus, Bifidobacterium, Enterococcus, and Streptococcus are common in 
commercial products, which are often comprised of multiple species (Yirga, 2015). Their 
effectiveness is dependent upon their ability to be prepared on a large scale, provide 
beneficial effects on the host, and their capacity to tolerate various environmental pressures 
during processing, storage, and passage through the gastrointestinal tract of the animal 
(Bajagai, 2016). These bacteria must also be resistant to gastric acid, digestive enzymes, 
and bile acids to survive in the gastrointestinal tract (Larsen et al., 2014). Several 
mechanisms of action have been proposed by which DFMs exert effects on the animal and 
improve growth performance, including, but not limited to: production of antimicrobial 
compounds and enzymes (Kunst et al., 1997), enhanced nutrient digestibility (Meng et al., 
2010; Giang et al., 2010; Jørgensen et al., 2016), promotion of beneficial bacteria growth 
(Baker et al., 2013; Hu et al., 2014; Cui et al., 2013), competitive exclusion of pathogenic 
bacteria (Tsukahara et al., 2013), immune response modulation (Lee et al., 2014; Yang et 
al., 2016), and improvements in intestinal barrier integrity (Baum et al., 2002; Yang et al., 





Direct-fed microbials are classified into 3 main categories: Bacillus, lactic acid-
producing, and yeast (Stein and Kil, 2006, NRC, 2012). The Bacillus genus has been 
substantially researched due to their ability to form endospores, produce exogenous 
enzymes and antimicrobial compounds, and beneficially alter the gut microbiota (Cutting, 
2011). Bacillus spp. Are gram-positive, facultatively anaerobic, and spore-forming 
organisms, making them highly stable at various temperatures and low pH (Nicholson et 
al., 2000; Setlow, 2006). These characteristics allow them to survive pelleting and 
extrusion processes, storage, as well as the unhospitable environment of the pig’s stomach; 
however, survival through the stomach does not guarantee the DFM will exert beneficial 
effects on the animal. From 245 bacterial isolates, Larsen et al. (2014) identified B. 
amyloliquefaciens , B. subtilis and B. mojavensis as three strains with the best 
characteristics regarding pathogen inhibition, spore-forming ability, antibiotic resistance, 
and enzyme production, making them strong potential candidates for DFMs. For the 
purposes of this review, emphasis will be placed on Bacillus-based DFM products. 
Efficacy of direct-fed microbials 
The ability of Bacillus-based DFMs to improve ADG, ADFI, and feed efficiency 
in pigs has been well documented. Wang et al. (2017) reported an increase in ADG and 
ADFI in nursery pigs fed B. amyloliquefaciens compared to pigs fed an antibiotic. In 
weaned pigs fed a DFM blend of B. subtilis and B. amyloliquefaciens, improvements in 
feed efficiency have been observed (Cai et al., 2015; Jaworski et al., 2017). In a 14-d study 
evaluating the effects of a water-delivered Bacillus-based DFM, increased ADG in weaned 
pigs following a Salmonella infection was observed. (Walsh et al., 2012). Similarly, Pan et 





with B. licheniformis and Saccharomyces cerevisiae compared to a non-challenged control. 
Addition of B. licheniformis and B. subtilis in pig diets from wean to finish has been shown 
to reduce morbidity and mortality (Alexopoulos et al., 2004b). These improvements in 
performance can partly be credited to enhanced nutrient digestibility resulting from 
exogenous enzyme production (Ferrari et al., 1993; Jørgensen et al., 2016; Lan et al., 2016; 
Payling et al., 2017).  
DFM supplementation in pigs has been shown to positively influence intestinal 
barrier function, as well as immune responses. Hu et al. (2018) reported that pigs fed B. 
amyloliquefaciens significantly increased amylase, sucrase, maltase, and Na+/K+-ATPase, 
indicating a positive influence on intestinal barrier integrity. Increases in serum 
immunoglobulins IgA and IgG in pigs fed B. subtilis have been observed (Kunavue and 
Lien, 2012; Lee et al., 2014). These immunoglobulins are known to play a critical role in 
clearing foreign pathogens. Results regarding intestinal morphology in nursery pigs fed a 
Bacillus-based DFM have been conflicting. Cai et al. (2015) reported a blend of 1 strain of 
B. subtilis and 2 strains of B. amyloliquefaciens increased villus height in the duodenum 
and jejunum of weaned pigs; however, others have shown no effect of DFM 
supplementation on villus height (Walsh et al., 2007; Choi et al., 2011). Bhandari et al. 
(2008) also reported no change in intestinal villus height in pigs subjected to an ETEC 
challenge with DFM supplementation. While limited data exist regarding Bacillus-based 
DFM supplementation in ETEC challenged pigs, Tsukahara et al. (2013) observed a 
reduction of pathogenic bacteria in the ileal digesta and feces of pigs fed B. subtilis and 





Healthy gut microbial populations contribute to enhanced performance and 
immunity. DFMs are known to balance the GIT microbial population dynamics in order to 
create a more beneficial microbial population. This beneficial modulation may begin as 
early as gestation, as demonstrated by Baker et al. (2013). In sows fed a diet supplemented 
with B. subtilis, nursing piglets had a greater abundance of Lactobacillus in the ileum and 
lower E. coli numbers in the colon at 3 days old. In MUC4-resistant piglets orally 
administered B. licheniformis and B. subtilis, attenuated growth of Bacteroides uniformis, 
Eubacterium eligens, Acetanaerobacterium, and Sporobacter populations was observed 
following an ETEC challenge, while Clostridium, Turicibacter, and Lactobacillus 
populations increased. An increase in ileal goblet cells and MUC2 production also 
occurred, indicating enhanced GIT defense and preservation of the mucosal barrier against 
an ETEC challenge (Zhang et al., 2017). Hu et al. (2013) observed an increase in the 
relative number of fecal Lactobacillus and a corresponding decrease in E. coli in weaned 
pigs fed Bacillus subtilis KN-42, as well as an increase in bacterial diversity. These results 
agree with Lan et al. (2016), in which supplementation of pigs with a mixture of B. 
coagulance, B. lichenformis, B. subtilis, and Clostridium butyricum resulted in higher fecal 
Lactobacillus counts and lower E. coli counts. Similarly, Payling et al. (2017) reported an 
increased in fecal Lactobacillus in growing pigs fed three Bacillus strains.  
Sources of variability 
Despite the several studies reporting beneficial effects of Bacillus-based DFM 
products, results in pigs are inconsistent. While many researchers have observed 
improvements in growth performance, other studies have reported no effects of DFM 





(Chen et al., 2006; Walsh et al., 2007). Several sources of variability are observed across 
studies evaluating DFMs, making it difficult to compare results. Studies vary in 
experimental design, stage of production, DFM species, strain, dose and application, 
adaptation time, sample collection, and inclusion of a challenge. Dietary ingredient 
composition is also a key factor; however, limited research has evaluated the interactions 
between DFM products and feed ingredients. Additionally, there may be further 
inconsistencies when assessing single strain or multi-strain DFM products. Improvements 
in genetics and pork production practices may also influence DFM efficacy between 
studies. There is strong evidence that the gut microbiota are constantly evolving, and as the 
swine industry continues to reduce the use of antibiotics and pharmacological levels of 
minerals, development of new DFM products with strains that are more relevant to the 
pig’s changing GIT environment may be necessary.  
 
Conclusions 
In piglets, gastrointestinal function following weaning is closely associated with 
their subsequent growth performance and economic values. GIT disruption and 
immunological stimulation due to ETEC infections after weaning have negative 
consequences on the pig’s ability to intake feed and uptake nutrients, resulting in reduced 
growth, increased morbidity, and potentially death. The GIT and mucosal immune systems 
are large and complex features strongly impacted by ETEC. In order to develop 
interventions to control or prevent ETEC, more comprehensive research evaluating 
intestinal barrier function, localized and systemic immune response, and gut microbiota 





especially Bacillus-based DFMs, in nursery pig diets is a nutritional strategy that shows 
great promise to improve pig growth performance and gut health following weaning; 
however, a better understanding of their mode of action, particularly under pathogenic 
infection, is warranted. Therefore, the overall objective of this thesis research was to 
investigate the physiological impact of an ETEC challenge in weaned pigs and to 
understand the effects of supplementing Bacillus-based direct-fed microbial blends in both 
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Abstract 
 Direct-fed microbial blends have been proposed as non-antibiotic nutritional 
interventions to prevent or mitigate weaning stress. These feed additives may interact with 
a host’s gastrointestinal tract, immune system, and microbiota, and could potentially 
improve animal production and minimize economic losses. The experimental objective 
was to evaluate the effects of two novel Bacillus-based direct-fed microbial blends on 
nursery pig growth performance. A total of 480 weaned pigs (5.6 ± 0.2 kg BW; L337 X 
Camborough, PIC, Inc., Hendersonville, TN) were blocked by initial BW, and pens (n = 
16 per treatment) were randomly assigned to 1 of 3 dietary treatments for a 35-d 
experiment. The diets were fed over 3 phases and included a basal control (CON) and the 
CON supplemented with 0.03% of either direct-fed microbial blend 1 (DFM1; 3 strains of 
Bacillus amyloliquefaciens) or DFM2 (1 strain of Bacillus subtilis and 2 strains of Bacillus 
amyloliquefaciens). Pigs and feeders were weighed on d 0 and d 35 to calculate BW, ADG, 
ADFI, and feed efficiency. Data were analyzed as a randomized complete block design 





fixed effect and block was a random effect. Over the 35-d experiment, ADG, ADFI, feed 
efficiency, and BW did not significantly differ (P > 0.05). Under the experimental 
conditions of this study, neither DFM product affected growth performance of nursery pigs 
compared to pigs fed a non-supplemented control diet.  
 
Introduction 
In commercial swine production, limitations in efficiency and profitably are often 
related to high mortality, morbidity, and poor growth performance during the post-weaning 
phase. Traditionally, antibiotics have been utilized to reduce morbidity and improve growth 
performance post-weaning; however, due to consumer demand, potential trade restrictions, 
and concern for antimicrobial resistance, United States pork production has moved towards 
limited antibiotic use in commercial practice. As a result, various nutritional interventions, 
such as direct-fed microbial blends (DFMs), organic acids, enzymes, phytobiotics, 
nucleotides, and essential oils are being investigated as non-antibiotic alternative dietary 
technologies. The critical objectives of using these products in livestock feed are to 
promote animal productivity and growth and alleviate the negative social, environmental, 
and health stressors piglets face after weaning.  
Direct-fed microbials, previously referred to as probiotics, contain live, viable 
microorganisms (FDA, 2015). Recently, direct-fed microbials have gained popularity in 
both the human and animal nutrition sectors due to their ability to exert beneficial health 
effects. Improvements in growth performance and feed efficiency have been observed with 
Bacillus-based DFM supplementation in nursery pig (Lee et al., 2014, Hu et al., 2014, 





performance benefits, Bacillus-based DFMs have been shown to have a favorable impact 
on intestinal health and function in the weaned pig (Cai et al., 2015). Though several 
mechanisms have been proposed by which DFMs exert their effects, the exact mode of 
action remains unknown. The differences in these mechanisms can be attributed to 
variation in DFM composition, dietary inclusion rate and composition, health status, 
production stage, and environment, resulting in a lack of consistent outcomes. Therefore, 
the objective of this study was to evaluate the effects of two novel Bacillus-based direct-
fed microbial blends on nursery pig growth performance in a commercial-like 
environment.  
 
Materials and methods 
 All experimental procedures adhered to guidelines for the ethical and humane use 
of animals for research and were approved by the Iowa State University Institutional 
Animal Care and Use Committee (IACUC #18-147). 
Animals, housing, and experimental design 
 A total of 480 weanling pigs (5.6 ± 0.2 kg BW; L337 X Camborough, PIC, Inc., 
Hendersonville, TN) were purchased and transported to the Iowa State University Swine 
Nutrition Farm (Ames, IA). Upon arrival, pigs were individually weighed, ear-tagged, and 
vaccinated for K88+ Escherichia coli via a water-delivered vaccine (Arko Laboratories, 
Jewell, IA). Pigs were blocked by initial weight and pens were randomly assigned to 1 of 
3 dietary treatments. There were 16 blocks, 10 pigs per pen, and 16 pens per treatment. 
Sexes were not separated, but there were the same number of barrows and gilts per pen 





Diets and feeding 
Pens (1.2 m × 2.4 m) were equipped with a four-space dry self-feeder and 2 nipple 
waterers to provide ad libitum access to feed and water. Pigs were fed experimental diets 
in 3 phases over 35 d. Phase 1 was offered for 7 d and phases 2 and 3 were each offered 
for 14 d. Diets were formulated to meet or exceed NRC (2012) nutrient recommendations. 
Dietary treatments consisted of a basal control diet (CON), CON supplemented with 3 
strains of Bacillus amyloliquefaciens (DFM1; Danisco Animal Nutrition, Marlborough, 
UK) and CON supplemented with 1 strain of Bacillus subtilis and 2 strains of Bacillus 
amyloliquefaciens (DFM2; Danisco Animal Nutrition, Marlborough, UK). The DFM 
products were supplemented at 0.03% of the basal control diet at the expense of corn to 
achieve 7.5  105 cfu DFM/g of complete feed and 1.5  105 cfu DFM/g of complete feed 
for DFM1 and DFM2, respectively (Table 2.1).  
Sample collection 
Pig BW and feed intake were measured on d 0 and 35 of the experiment to calculate 
ADG, ADFI, and G:F for the overall growth period. Multiple diet subsamples were 
collected as each was unloaded from the mixer. Samples were homogenized, subsampled, 
and stored at -20º C until later analysis.  
Analytical methods 
Diets were ground to 1 mm particle size with a Wiley Mill (Variable Speed Digital 
ED-5 Wiley Mill; Thomas Scientific, Swedesboro, NJ) and analyzed in duplicate for DM 
(method 930.15; AOAC, 2007) and acid-hydrolyzed ether extract (aEE; method 2003.06; 
AOAC, 2007). Diets were analyzed in duplicate for nitrogen (N; method 990.03; AOAC, 





standard for calibration and was determined to contain 9.55 ± 0.01% N. Crude protein was 
calculated as N  6.25. Gross energy was determined in duplicate using an isoperibolic 
bomb calorimeter (model 6200; Parr Instrument Co., Moline, IL). Benzoic acid (6318 kcal 
GE/kg; Parr Instrument Co.) was used as the standard for calibration and was determined 
to contain 6319 ± 0.8 kcal GE/kg.  
Statistical analysis 
Data were analyzed in a randomized complete block design using the MIXED 
procedure of SAS (SAS Institute Inc., Cary, NC). The UNIVARIATE procedure was used 
to check normality and equal variance of residuals. Pen was the experimental unit, 
treatment was a fixed effect, and block was a random effect. Differences among treatments 
were determined using ANOVA and means were separated using the PDIFF option of the 
least square means statement. Differences were considered significant if P was ≤ 0.05 and 
a tendency if 0.05 < P ≤ 0.10.  
 
Results and discussion  
By design, initial pig BW did not differ among treatments (P > 0.10; Table 2.2). 
Pigs fed the control diet tended to have a higher final BW compared to the other two 
treatments (d 35; P = 0.090). Average daily gain, ADFI, and feed efficiency were 
unaffected by DFM supplementation over the 35-d experimental period (P > 0.10). Several 
direct-fed microbial products have been researched, with variable results on growth 
performance in pigs. The absence of performance responses are in agreement with other 
studies that supplemented a DFM product in weaned pig diets (Keegan et al., 2004; 





Multiple factors possibly contribute to this lack of response to supplementation of 
either DFM product. First, herd health status could impact the effectiveness of DFM 
products. It is hypothesized that the production response to DFM supplementation would 
be greater in animals with a poor health status (McEwen and Fedorka-Cray, 2002). In the 
present study, there was no evidence of disease or diarrhea complications throughout the 
35 d period.  
Furthermore, DFM products contain live microorganisms whose efficacy is 
dependent upon longevity and proper storage conditions. The products used in this 
experiment were utilized and stored according to manufacturer recommendations.  
Pigs experience enteric dysbiosis following weaning, which includes large 
fluctuations in the microbial environment. Growth promotion of beneficial microbes, such 
as Lactobacilli and Bifidobacteria, and competitive exclusion of harmful bacteria are 
proposed mechanisms by which DFMs provide a benefit to the pig (Hu et al., 2014, Lan et 
al., 2016, Tsukahara et al., 2013). Though environmental factors and diet composition 
greatly influence the gut microbiota (Mann et al., 2014, Frese et al., 2015), it has also been 
suggested that host genetics play a role in gut microbiome development and composition 
(Goodrich et al., 2014, Kubasova et al., 2018). This may partially explain the variation in 
the growth responses with DFM supplementation observed across studies. 
Additionally, variability in diet composition could alter DFM efficacy. Minimal 
literature exists on the interactions of feed ingredients and DFM supplementation in pigs, 
specifically zinc. Addition of zinc oxide at high levels (2,000 – 4,000 mg/kg) to nursery 
diets is a common practice in U.S. pork production to improve growth performance and 





2002). In the present study, all phase 1 and 2 diets contained pharmacological levels of 
zinc oxide across all treatments. There is a paucity of data regarding the interaction between 
zinc and DFM products; however, alterations in fecal and intestinal microbiota of the pig 
due to zinc oxide and DFM supplementation, independent of one another, have been widely 
reported. Researchers have observed reductions in Lactobacillus, which are considered 
beneficial microorganisms in the gastrointestinal tract, in weaned pigs due to zinc oxide 
supplementation at pharmacological levels (Højberg et al., 2005, Vahjen et al., 2011, 
Starke et al., 2014). Supplementation of a Bacillus-based product to weaned pigs has been 
shown to increase Lactobacillus (Payling et al., 2017, Hu et al., 2013). These competing 
effects of zinc and DFM on the microbial population may have altered the efficacy of the 
DFMs or competitively inhibited the DFMs ability to elicit a phenotypic response in this 
study.   
In conclusion, under the conditions of this study, addition of either Bacillus-based 
DFM product did not alter body weight or growth performance of nursery pigs across the 
35-d period compared to pigs fed the basal control diet. Research evaluating the 
interactions of dietary feed ingredients and feed additives, as well as the interactions of 
multiple feed additives, is warranted.  
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Table 2.1. Ingredient composition of experimental diets (as-fed basis) for phases 1 – 31 
Item Phase 1 Phase 2 Phase 3 
Ingredient, %    
 Corn 32.24 53.84 63.87 
 Soybean meal 15.00 20.00 29.95 
 Whey permeate 15.00 5.00 -- 
 Oat groats 15.00 5.00 -- 
 HP300 11.58 7.24 -- 
 Blood plasma 4.50 2.00 -- 
 Soybean oil 3.00 3.00 3.00 
 Limestone 0.95 1.00 0.86 
 Monocalcium phosphate 0.85 0.97 0.86 
 Salt 0.23 0.53 0.30 
 Vitamin premix2 0.30 0.30 0.30 
 Trace mineral premix3 0.20 0.20 0.20 
 L-Lysine HCL 0.45 0.46 0.41 
 DL-Methionine 0.20 0.16 0.13 
 L-Threonine 0.12 0.12 0.12 
 Zinc oxide, 72%4 0.38 0.18 -- 
Dietary treatments delivered in mash form with each DFM (Danisco Animal Nutrition, 
Wilmington, DE) included in the diet at 0.03% at the expense of corn 
1Phase 1 = d 0 – 7; Phase 2 = d 7 – 21; Phase 3 = d 21 – 35  
2Provided 6,614 IU vitamin A, 827 IU vitamin D, 26 IU vitamin E, 2.6 mg vitamin K, 29.8 
mg niacin, 16.5 mg pantothenic acid, 5.0 mg riboflavin, and 0.023 mg vitamin B12 per kg 
of diet.  
3Provided 165 mg Zn (zinc sulfate), 165 mg Fe (iron sulfate), 39 mg Mn (manganese 
sulfate), 17 mg Cu (copper sulfate), 0.3 mg I (calcium iodate), and 0.3 mg Se (sodium 
selenite) per kg of diet.  








Table 2.2. Formulated and analyzed energy and nutrient composition (as-fed basis) 
Item Phase 1 Phase 2 Phase 3 
Formulated composition    
     ME, Mcal/kg 3.49 3.44 3.41 
     SID amino acid, %    
          Lys 1.50 1.35 1.23 
          Met 0.47 0.44 0.41 
          Total sulfur AA 0.82 0.74 0.68 
          Thr 0.88 0.79 0.73 
          Trp 0.27 0.23 0.21 
     Ca, % 0.85 0.80 0.70 
     STTD P, % 0.46 0.41 0.34 
Analyzed composition    
     DM, % 89.90 88.48 87.69 
     GE, kcal/kg 4389 4389 4432 
     CP, % 24.97 22.49 21.68 
aEE1, % 5.81 6.18 6.29 










Control DFM12 DFM23 
  d 0 BW, kg 5.65 5.63 5.64 0.28 0.421 
  d 35 BW, kg 17.19 16.67 16.73 0.50 0.090 
  ADG, kg  0.32 0.31 0.32 0.01 0.428 
  ADFI, kg  0.49 0.48 0.48 0.01 0.461 
  G:F  0.66 0.66 0.66 0.005 0.618 
1n=16 pens per treatment (main effect)  
2DFM1 (Danisco Animal Nutrition, Wilmington, DE) was included at 0.03% to achieve a 
final dose of 7.5x105 cfu/g of feed 
3DFM2 (Danisco Animal Nutrition, Wilmington, DE) was included at 0.03% to achieve a 
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Abstract 
The objective of this experiment was to investigate the impact of an F18 
enterotoxigenic Escherichia coli (ETEC) challenge on growth performance, intestinal 
function, and immune response of piglets, as well as to evaluate potential protective effects 
of direct-fed microbial blends. Seventy-two weaned piglets (6.4  0.6 kg BW; ~21 d of 
age) were assigned to one of four treatments: 1) NC: Non-challenged (n=10), 2) PC: F18 
ETEC challenged (n=10), 3) PC + DFM1 (n=8; 3 strains of Bacillus amyloliquefaciens; 
7.5  105 cfu/g) or 4) PC + DFM2 (n=8; 2 strains of Bacillus amyloliquefaciens and 1 
strain of Bacillus subtilis; 1.5  105 cfu/g). Pigs were housed two pigs per pen to record 
BW and feed intake on d 0, 7, and 17. Pigs were either sham-infected with 6 mL phosphate-
buffered saline or orally inoculated with 6 mL hemolytic F18 ETEC (~1.9 × 109 CFU/mL) 




genetically susceptible to F18 ETEC. Pigs had ad libitum access to feed and water 
throughout the 17-d trial. Fecal scores were visually ranked and rectal temperatures were 
recorded daily. To evaluate E. coli shedding, fecal swabs were collected on dpi 0, 1, 2, 3, 
5, 7, and 10. Blood samples were collected on dpi 0, 1, 2, 4, 7, and 10. Ileal tissues were 
collected at necropsy. All challenged treatments had lower final BW, decreased ADG, and 
ADFI during the 10-d challenge period (P < 0.01). The DFM2 treatment increased E. coli 
shedding on dpi 2 (P < 0.05) and decreased shedding on dpi 7 (P < 0.05) compared with 
PC. Rectal temperature was decreased across all challenged treatments (P < 0.01). Ileal 
mRNA abundance of occludin (OCLN) and zonula occludens-1 (ZO-1) decreased in PC 
and DFM1 compared with NC (P < 0.05). Pigs fed DFM2 had intermediate ileal mRNA 
abundance of OCLN and increased ZO-1 mRNA compared with pigs on PC (P < 0.05). 
Interleukin 8 (IL-8) increased in the plasma of PC and DFM2 on dpi 2 compared with NC 
(P < 0.05). Mucosal IL-8 increased in PC compared with NC (P < 0.05). All challenged 
treatments tended to have elevated tumor necrosis factor- (TNF) mRNA abundance 
compared with NC (P < 0.10). Challenged pigs had reduced secretory immunoglobulin A 
and villus height compared with non-challenged pigs (P < 0.05). Overall, DFM1 did not 
appear to attenuate the impacts of ETEC; however, DFM2 may provide some protection to 
nursery pigs challenged with ETEC by improving intestinal barrier integrity. 
 
Introduction 
There is a growing interest in reducing or eliminating antibiotic use in livestock 
production due to growing regulatory constraints, concerns about antimicrobial resistance, 




consequences compared to other production stages due to social and environmental 
stressors adversely affecting gastrointestinal function and the immune system, leading to 
increased incidence of disease, including diarrhea (Hao et al., 2014). Enterotoxigenic 
Escherichia coli (ETEC) infections are a major cause of post-weaning diarrhea (PWD) in 
nursery piglets worldwide. ETEC attach to the intestinal epithelium via fimbria, commonly 
F4 or F18. This leads to subsequent pathogen proliferation and secretion of enterotoxins, 
resulting in secretory diarrhea in nursery pigs. A decrease in the rate and efficiency of body 
weight gain combined with increased death loss following an ETEC infection results in 
considerable economic losses. Vaccines and antibiotics have been used to prevent and 
control ETEC infections in nursery barns for many years; however, alternative strategies 
are needed. Utilization of in-feed direct-fed microbials (DFM) are being developed as a 
means of preventing and mitigating PWD. Direct-fed microbials are defined as products 
that “contain live naturally occurring microorganisms” (FDA, 2015). These products 
typically consist of single or multiple bacterial strains and often include Bacillus species. 
In pigs, DFMs have been shown to enhance growth performance (Alexopoulus et al., 
2004), improve intestinal function (Scharek et al., 2007; Yang et al., 2016), and positively 
modulate immune responses and microbial populations (Lan et al., 2016). Despite these 
observed beneficial effects, results derived from swine studies are inconsistent. Currently, 
there is limited information regarding the impact of DFM supplementation in ETEC 
challenged pigs. Therefore, the objective of this study was to evaluate the impact of an 
ETEC challenge on growth performance, intestinal barrier function, and immune response 





Materials and methods 
 All experimental procedures adhered to guidelines for the ethical and humane use 
of animals for research and were approved by the Iowa State University Institutional 
Animal Care and Use Committee (IACUC #8-17-8576-S). 
Animals, Diets, and Experimental Design 
 A total of 72 weaned pigs (6.4  0.6 kg BW; ~21 d of age; L337   Camborough, 
PIC, Hendersonville, TN) were individually weighed and allotted to pens such that there 
were one barrow and one gilt per pen. Pens were randomly assigned to one of four dietary 
treatments: a non-challenged control (NC; n = 10), an ETEC challenged control (PC; n = 
10), PC + DFM1 (3 strains of Bacillus amyloliquefaciens; DFM1; n = 8), and PC + DFM2 
(2 strains of Bacillus amyloliquefaciens and 1 strain of Bacillus subtillis; DFM2; n = 8). 
The DFM1 and DFM2 were included at 0.03% of the diet to achieve a final dose of 7.5  
105 cfu/g of feed and 1.5  105 cfu/g of feed, respectively (Danisco Animal Nutrition, 
Marlborough, UK). The control diet was presented in mash form and was primarily based 
on corn and soybean meal with 9.0% whey powder and 8.5% enzymatically treated 
soybean meal. The DFM1 and DFM2 were added to replace corn in the control diet. The 
diets were formulated to meet or exceed NRC (2012) nutrient recommendations of weaned 
pigs and did not contain antibiotics or pharmaceutical levels of copper or zinc (Table 3.1).  
 This trial was conducted in a biosecurity level 2 facility at Iowa State University. 
Pigs were housed in 1 of 2 separate rooms based on their challenge status: 1 smaller room 
with 20 non-challenged control pigs (10 pens) and a second larger room with 52 challenged 
pigs (26 pens). Room temperature, humidity, and lighting were carefully monitored 




space and flooring material. A four-space polyethylene dry feeder and one nipple drinker 
were used to provide ad libitum access to feed and water throughout the 17-day experiment. 
To avoid ETEC contamination in the non-challenged room, strict biosecurity protocols 
were followed. Pigs’ genetic susceptibility to F18 ETEC was tested via Sanger DNA 
sequencing of the α (1,2) fucosyltransferase-1 (FUT1) gene (Frydendahl et al. 2003). The 
F18 ETEC isolate used in this study was obtained from the culture collection at the Iowa 
State University Veterinary Diagnostic Laboratory (ISU VDL; Ames, IA). After 7 days of 
acclimation (0 day post-inoculation: dpi), pigs were orally gavaged with 6 mL of freshly 
grown F18 ETEC inoculum (approximately 1.9  109 cfu/mL) or sham-infected with PBS. 
The sows and piglets used in this experiment had not been previously vaccinated against 
E. coli. 
Inoculum Preparation 
A fluoroquinolone-resistant hemolytic E. coli isolate with an enrofloxacin minimal 
inhibitory concentration (MIC) > 2 g/mL was used to prepare the bacterial inoculum at 
the ISU VDL. A resistant isolate was selected in order to improve the specificity of 
recovery via selective media post-inoculation. Briefly, a frozen culture stock of the isolate 
was grown (~ 16 h at 37°C) on blood agar (TSA with 5% sheep blood) and was used to 
inoculate two bottles, each containing 50 mL of sterile TSB. The bottles were incubated 
overnight at 37°C with shaking. The broth cultures were then transferred to two new sterile 
bottles each with 450 mL fresh TSB and incubated for an additional 5 h at 37°C with 
shaking. The bacterial culture was centrifuged and the pellet was suspended in 900 mL of 




spectrophotometer. A viable CFU count was performed and the inoculum was determined 
to have approximately 1.9 × 109 cfu/mL. 
Sample Collection 
Pigs were individually weighed on dpi -7, 0, and 10. Feed disappearance was also 
recorded to calculate ADG, ADFI, and G:F for each phase. On dpi 0, 1, 2, 3, 5, 7, and 10, 
fecal swabs were collected from one barrow per pen to evaluate F18 ETEC shedding. 
Rectal temperatures were obtained daily from every pig via rapid-response digital electric 
thermometers (ReliOn, MABIS Healthcare Inc., Waukegan, IL). Pen fecal score was 
visually assessed daily by two unbiased personnel using the following scale: 0 = solid, 1 = 
semi-solid, 2 = semi-liquid, and 3 = liquid. Fecal score ≥ 2 was considered diarrhea. On 
dpi 0 (immediately before inoculation), 1, 2, 4, 7, and 10, blood samples were collected 
from 1 barrow per pen via jugular venipuncture into a 10 mL vacutainer tube (Bection 
Dickinson, Franklin Lakes, NJ). Plasma was separated by centrifugation (2000 × g for 10 
min at 4°C), divided into three aliquots, and stored at -80°C for later analysis.  
On dpi 10, one pig from each pen was euthanized by captive bolt stunning followed 
by exsanguination. Post-euthanasia, the abdomen was opened and a 30 cm segment of 
ileum anterior to the ileocecal junction was removed, drained of digesta, and rinsed with 
ice-cold PBS. Three 2 cm segments of the terminal ileum were fixed in 10% neutral 
buffered formalin. The remaining ileal segments were snap frozen in liquid N and stored 
at -80°C for later analysis. A second 20 cm segment of ileum was removed, snap frozen in 






Diets were ground to 1 mm particle size with a Wiley Mill (Variable Speed Digital 
ED-5 Wiley Mill; Thomas Scientific, Swedesboro, NJ) and analyzed in duplicate for DM 
[method 930.15 (AOAC, 2007)], acid-hydrolyzed ether extract [aEE; method 2003.06; 
(AOAC, 2007)], and N [method 990.03 (AOAC, 2007); TruMac; LECO Corp., St. Joseph, 
MI]. An EDTA sample (9.56% N) was used as the standard for calibration and was 
determined to contain 9.55 ± 0.01% N. Crude protein was calculated as N x 6.25. Gross 
energy was determined in duplicate using an isoperibolic bomb calorimeter (model 6200; 
Parr Instrument Co., Moline, IL). Benzoic acid (6,318 kcal GE/kg) was used as the standard 
for calibration and was determined to contain 6,319 ± 0.8 kcal GE/kg.  
Fecal F18 E. coli shedding  
For isolation of E. coli from fecal samples, fecal swabs were plated onto selective 
TSA agar with 5% bovine blood, 16 µg ciprofloxacin/mL, and 50 µg cycloheximide/mL 
and a MacConkey agar plate. Plates were incubated at 37°C for 24 h to determine hemolytic 
E. coli shedding using a semi-quantification method. ETEC shedding was measured using 
a 5-point scale ranging from 0 to 4 according to the number of streaked sections that had 
viable E. coli, where 0 corresponded to no growth, 1 corresponded to growth in the primary 
streak, 2 corresponded to compatible growth extending into the secondary streak, 3 
corresponded to growth into the tertiary streak and 4 corresponded to growth of pathogenic 
E. coli into the quaternary section of the agar plate. Identification of E. coli isolates was 
confirmed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry 





Ileal E. coli attachment 
Formalin-fixed ileum tissues were processed and embedded in paraffin wax at the 
ISU VDL. Three transverse sections (5 μm) were cut from the ileum, stained with 
hematoxylin and eosin, and mounted on glass slides. Visualization of E. coli attachment to 
epithelial cells was accomplished using an OLYMPUS BX 53/54 microscope at 40X 
power. Each section was scored as either 0 if there was no attachment or 1 if there was 
attachment of E. coli on  5 villi in each section. The E. coli attachment frequency (%) was 
calculated by summing up the score of all 3 sections on each glass slide and then dividing 
by 3. 
Intestinal Morphology 
Images of ileal sections were taken using a DP80 Olympus Camera mounted on an 
OLYMPUS BX 53/43 microscope with a motorized stage. Whole ileal sections were 
scanned at 4X power, then regions containing well-orientated villus and crypt pairs were 
selected. These regions were rescanned at 20X power. The 20X regions were stitched 
together to form a composite image. Ten well-orientated villus and crypt pairs per ileal 
section per slide were selected and analyzed using OLYMPUS cellSens Dimension 1.16 
software.  
RNA isolation and quantitative PCR 
 Approximately 30 mg of ileal tissue was homogenized using the Qiagen Tissuelyser 
II (Germantown, MD, USA), then total RNA was isolated using the Qiagen Rneasy Mini 
Kit according to the manufacturer’s recommendations. The concentration of RNA was 
quantified using a spectrophotometer (ND-100; NanoDrop Technologies, Inc., Rockland, 




Kit (Qiagen GmbH, Hilden, Germany) was used according to the manufacturer’s 
instructions to synthesize complementary DNA (cDNA) from 0.8 μg of the isolated RNA. 
All cDNA samples were diluted 10-fold with nuclease-free water.   
Real-time quantitative PCR was performed using iQ SYBR Green Supermix (Bio-
Rad Laboratories, Inc., Hercules, CA). The gene-specific primers, shown in Table 3.2, 
were diluted to 10 µM with nuclease-free water. Genes were chosen to evaluate small 
intestinal inflammatory status and paracellular permeability. Ribosomal protein – L19 
(RPL19) was included as an endogenous reference gene. Each reaction included 10 µL of 
SYBR Green Supermix, 1 µL of each forward and reverse primer, 5 µL of nuclease-free 
water, and 3 µL of cDNA, for a total of 20 µL reaction volume. Each 96-well plate 
contained a no-reverse transcriptase negative control and a pooled cDNA reference sample. 
Samples were assayed in triplicate. Fluorescence of SYBR Green was quantified with a 
Real-time PCR Detection System (iQ5; Bio-Rad Laboratories Inc.). Cycling conditions 
were as follows: 5-min initial denaturation at 95°C followed by 40 PCR cycles (95°C for 
30 s, 55°C for 30 s, and 72°C for 30 s) and a dissociation curve to verify the amplification 
of a single PCR product. Optical detection was performed at 55°C. Analyses of 
amplification plots were performed with an Optical System Software version 2.0 (iQ5; Bio-
Rad Laboratories Inc.) and cycle threshold (Ct) values for each reaction was obtained. The 
mRNA abundance for each sample was normalized to RPL19 and the pooled sample, and 
fold change was calculated using the 2-ΔΔCTmethod (Livak and Schmittgen, 2001).  
Mucosal disaccharidase activity, secretory IgA, and cytokines 
Ileal mucosal scrapings (0.5 g) were added to 4.5 mL of PBS containing a protease 




was homogenized and centrifuged at 10,000 × g for 15 min at 4°C and the supernatant was 
stored in aliquots. Total protein concentration of hydrolyzed mucosa was quantified using 
a Pierce bicinchoninic acid (BCA) Protein Assay kit (Thermo Scientific, Woltham, MA). 
Disaccharidase activity was determined as previously described by Dahlqvist (1964) using 
lactose, maltose, and sucrose as substrates. Enzyme activity was expressed as mol 
hydrolyzed substrate × min-1×g tissue protein-1. Concentration of secretory IgA was 
obtained using a porcine-specific ELISA kit following manufacturer’s instructions (Bethyl 
Laboratories, Inc., Montegomery, TX). Homogenized mucosa and plasma subsamples 
were analyzed for cytokines using a Multiplex Immunoassay (Eve Technologies, Calgary, 
AB, Canada).  
Statistical Analysis 
Data were analyzed as a complete randomized design. Pen was the experimental 
unit and treatment was a fixed effect. Growth performance data and plasma cytokines were 
analyzed as repeated measures with using the MIXED procedure of SAS (SAS Institute 
Inc., Cary, NC) with a spatial power covariance structure. Baseline (d 0) measurements of 
plasma cytokines were used as a covariate. ETEC shedding scores were analyzed using 
PROC MIXED as repeated measures using a spatial power covariance structure with pig 
as a random effect. Averaged fecal scores and rectal temperatures were analyzed using 
PROC MIXED as repeated measures with a first order autoregressive covariance structure. 
Mucosal cytokines, morphology, secretory IgA, disaccharidase, and mRNA abundance 
data were analyzed in PROC MIXED. ETEC attachment data were analyzed in PROC 
GLIMMIX assuming a binomial distribution. Least square means of treatments were 




evaluate the effects of the ETEC challenge (NC vs. PC) and dietary treatment (PC vs. 
DFM1, DFM2). For each variable, normal distribution of residuals was tested using PROC 
UNIVARIATE. Differences were considered significant if P was ≤ 0.05 and a tendency if 
P was > 0.05 and ≤ 0.10.  
Results 
Growth Performance 
Among challenged pigs, 23% mortality was observed, with no differences among 
treatments (data not shown). During the 7-d adaptation period, there were no significant 
differences in ADG or ADFI among the four treatments (P ≥ 0.466; Table 3.3). Pigs 
receiving either DFM product had increased G:F during the 7-d adaptation period (P = 
0.005). Pig BW did not differ on dpi -7 or dpi 0 (P ≥ 0.785). As expected, the pigs receiving 
the PC, DFM1, and DFM2 treatments had lower final BW (P <.0001) and lower ADG (P 
<.0001) during the 10-d challenge period compared with the NC. The NC pigs also had a 
higher feed intake than pigs on the other three treatments (P <.0001). The G:F during post-
challenge period was not different among all treatments (P = 0.203).  
ETEC shedding, fecal score, and rectal temperature 
 Overall fecal score for the 10-d challenge period for NC was lower compared with 
the challenged treatments (P <.0001, Fig. 3.1). There were no differences in fecal scores 
among challenged treatments over the 10-d challenge period (P > 0.10). Pigs on NC had 
no ETEC shedding throughout the experiment (Fig. 3.2). The DFM2 treatment increased 
ETEC shedding score (SS) on dpi 2 (P = 0.044) and decreased SS on dpi 7 (P = 0.003) 
compared with PC. There were no differences in SS between PC and DFM1 (P > 0.10). 




10-d challenge period, there was a significant reduction in rectal temperature across all 
challenged pigs compared with NC (P <.0001; Fig. 3.3). There were no differences in rectal 
temperature among challenged pigs (P > 0.10). 
Mucosal and plasma cytokines  
 Analysis of ileal mucosa cytokines revealed no differences among treatments for 
interferon- (IFN), interleukin-1rα (IL-1rα), IL-1α, IL-1ß, IL-2, IL-4, IL-6, IL-10, IL-12, 
or IL-18 (P > 0.10; Table 3.4). Mucosal IL-8 was elevated in PC compared with NC (P = 
0.011); however, there were no differences among challenged treatments. Similarly, there 
were no differences in plasma cytokines among treatments (data not shown) with the 
exception of IL-8. While there were no differences among challenged treatments, IL-8 
tended to be elevated in PC vs. NC (P = 0.069; Fig. 3.4) on dpi 1 and significantly elevated 
on dpi 2 (P = 0.031). There were no differences in plasma IL-8 on dpi 4, 7, or 10 among 
all treatments (P > 0.10). 
Mucosal Secretory IgA and disaccharidases  
 Secretory IgA was reduced in ileal mucosa of all challenged treatments compared 
with the NC (P = 0.011; Table 3.4). Lactase activity did not differ among treatments (P = 
0.511). Sucrase activity increased in PC and DFM2 compared with NC (P = 0.003). Pigs 
fed DFM1 had reduced sucrase activity compared with PC. The PC and DFM2 also had 
increase maltase activity compared with NC (P = 0.004); there was no difference between 
PC and DFM1 (P > 0.10). 
Ileal gene transcription 
 There were no differences among treatments in toll-like receptor 4 (TLR4) mRNA 




3.5). A trend for greater TNFα mRNA abundance was observed across all challenged 
treatments compared with NC (P = 0.087). Occludin (OCLN) mRNA abundance was 
significantly reduced in PC and DFM1 compared with NC (P = 0.045). Pigs receiving 
DFM2 had OCLN mRNA abundance intermediate of NC and PC. Lower zonula-
occludens-1 (ZO-1) mRNA abundance was observed in PC and DFM1 compared with NC 
and DFM2 (P = 0.001). Cluster of differentiation (CD14) was elevated in DFM2 compared 
with NC and PC (P = 0.019). Pigs receiving DFM1 had CD14 mRNA abundance 
intermediate of PC and DFM2. 
Morphology and E. coli attachment to epithelial cells 
 Villus height in the ileum was reduced across all challenged treatments compared 
with NC (P <.0001; Table 3.6). Ileal crypts tended to be shallower in pigs fed DFM1 (P = 
0.074). Villus height:crypt depth was reduced in DFM1 vs NC (P = 0.046). There were no 
differences in villus height:crypt depth among NC, PC, and DFM2. E. coli attachment to 
the epithelial cells in the ileum did not differ across all treatments (P = 0.101). 
 
Discussion 
 Rate and efficiency of body weight gain in newly weaned pigs is closely associated 
with intestinal health and function. Enterotoxigenic E. coli infections after weaning reduce 
feed intake and negatively impact gut health and intestinal function in the pig. Limited 
research exists evaluating the impact of Bacillus-based DFM products in ETEC challenged 
pigs. This study evaluated the effects of two novel Bacillus-based DFMs on growth 
performance, intestinal function, and immune response in weaned pigs challenged with 




scores and shedding of the F18 ETEC strain compared with NC, confirming the challenge 
model was successful. Final BW, and post-challenge ADG and ADFI were reduced in 
ETEC challenged pigs, as expected, though this did not result in a difference in feed 
efficiency compared with the NC. The lack of difference in feed efficiency was likely due 
to the significant decreases in both ADG and ADFI. The lack of difference in feed 
efficiency and reductions in pig growth performance due to an ETEC challenge are in 
agreement with previous research (Pan et al., 2017; Li et al., 2019).  
 While there were no differences in F18 ETEC shedding of challenged pigs across 
the 10-d challenge period, pigs supplemented with DFM2 had increased ETEC shedding 
on dpi 2, followed by a decrease in shedding on dpi 7 compared with PC. Despite the fact 
that the exact modes of action of Bacillus-based DFMs are unknown, the decrease in E. 
coli shedding on dpi 7 is possibly due to the ability of the DFM to successfully compete 
for carbon and energy sources and nutrient absorption sites, thereby suppressing growth of 
pathogenic bacteria (Cho et al., 2011). Members of the Bacillus genus have also been 
widely reported to produce bacteriocins, which are proteins with antimicrobial properties 
that can inhibit activity of pathogenic bacteria (Abriouel et al., 2011; Larsen et al., 2014). 
The ETEC challenge also reduced rectal temperatures across all challenged treatments 
compared with NC. This lack of febrile response is consistent with the absence of systemic 
cytokine and chemokines production, which is known to initiate a febrile response (Evans 
et al., 2015). To our knowledge, there is no published literature reporting a decrease in 
rectal temperature due to ETEC challenge; however, reductions in rectal temperature have 
been reported due to decreased feed intake (Pearce et al., 2013), which in turn presumably 




 In addition to clinical symptoms, ETEC is known to increase intestinal permeability 
through alterations in tight junction proteins. The reductions of OCLN and ZO-1 mRNA 
abundance due to ETEC infection observed in this study are in agreement with other reports 
(Ewaschuk et al., 2011; Gao et al., 2013; Li et al, 2019). The greater mRNA abundance of 
OCLN and ZO-1 in ETEC challenged pigs fed DFM2 compared with PC indicates an 
improvement in intestinal barrier integrity, potentially resulting from the initial increases 
and subsequent decreases in E. coli shedding. The ability of Bacillus-based products to 
improve tight junction protein expression has been previously described (Gu et al., 2014; 
Rhayat et al, 2019). Intestinal barrier preservation is partly dependent upon tight junction 
proteins, as they have an important role in preventing paracellular transport of harmful 
bacteria and toxins across the intestine (Mukiza et al., 2013). Transport of luminal contents 
and pathogenic material into the peripheral circulation can increase when tight junctions 
are disrupted, thus activating an immune response and intestinal inflammation. Activation 
of intestinal inflammation was indicated by elevated levels of ileal CD14, a co-receptor of 
the TLR-4 complex, which recognizes the lipopolysaccharide component of gram-negative 
bacteria (Guo et al., 2013). The upregulation of CD14 possibly explains the increase in the 
pro-inflammatory cytokine IL-8 observed in both the intestinal mucosa and plasma of PC 
compared with NC, which has been previously reported following an ETEC challenge (Li 
et al., 2019). However, pigs receiving either DFM product had intermediate IL-8 levels in 
the ileal mucosa, suggesting the ability of the DFMs to blunt this response. Roselli et al. 
(2007) reported increased levels of IL-8 accompanied by disruption in the tight junction 
complex following an ETEC infection, which agrees with these results. These data provide 




however, there was no difference in systemic IL-8 at dpi 10. This localized pro-
inflammatory response may be associated with the negative impacts on the intestinal 
barrier observed in PC. The lack of differences observed in other pro-inflammatory 
cytokines, such as IL-6 and TNF, in both the blood and tissue are likely due to the fact 
that pigs were recovering from ETEC infection by necropsy day on dpi 10, which is 
supported by the decreases in fecal scores, ETEC shedding, and E. coli attachment to the 
intestinal epithelium.  
 To further evaluate intestinal immune response, sIgA was measured in the ileal 
mucosa. The mucosal immune system is critical in protecting the host from pathogens. 
Secretory IgA is the most abundant antibody found in the intestine, serving as the first line 
of barrier defense of the mucosal immune system in the event of an enteric infection 
(Mantis et al., 2011). In the current study, sIgA levels were reduced due to ETEC challenge, 
which is inconsistent with previous literature (Zhang et al., 2013). This is possibly 
explained by a mechanism used by sIgA known as immune exclusion, which inhibits the 
ability of pathogens and toxins to interact with the intestinal epithelium. Once bound, sIgA 
facilitates bacterial clearance by increasing peristaltic movement in the GIT (Mantis et al., 
2011). Thus, the majority of sIgA produced may have been shed with the GIT contents. 
Additionally, sIgA can intercept incoming pathogens intracellularly as it is crossing the 
epithelial barrier, as well as neutralize pathogens that have successfully crossed the 
intestinal barrier into the lamina propria (Corthésy, 2013). Due to the observed impairment 
in intestinal barrier integrity, sIgA may be acting at these sites to neutralize pathogenic 
agents instead of at the mucosal surface. Additionally, it has been established that mucosal 




study, villus height was significantly reduced across all challenged treatments, which has 
been associated with weaning and ETEC challenges (Pluske et al., 1997; Yang et al., 2014). 
The observed villus atrophy may have resulted in less mucosal mass in the intestine and 
therefore less surface area for sIgA to bind to. 
 Intestinal function was also assessed by measuring disaccharidase activity in the 
ileum. Improvements in disaccharidase activity are indicative of improved digestive 
capacity. While no difference in lactase activity was observed, PC and DFM2 had increased 
sucrase and maltase activity compared with NC. It has been shown that DFM 
supplementation in pig diets increases amylase, sucrase, maltase, and Na+/K+-ATPase 
activities (Hu et al., 2018), which is reflective of improved intestinal function. There is 
little information regarding the impact of an ETEC challenge on disaccharidase activity; 
however, authors reported increases in maltase activity in early weaned-pigs, which was 
closely correlated with corresponding mRNA levels, suggesting a large impact of 
transcriptional regulation of maltase after weaning (Marion et al., 2005). Increases in 
intestinal disaccharidase activities may also signify indirect effects of reduced feed intake.  
 In conclusion, these results provide insight into how a severe ETEC infection 
impacts growth performance, intestinal function, and immune response in weaned pigs. 
Weaned pigs challenged with F18 ETEC had reduced BW, ADFI, and ADG, which 
resulted from colonization of pathogenic E. coli as supported by increases in shedding and 
fecal scores, and reduced body temperature. While no apparent beneficial effects of DFM1 
supplementation were observed, DFM2 appeared to partially attenuate the ETEC challenge 
by decreasing E. coli shedding following inoculation, which resulted in improvements in 




impaired intestinal barrier integrity, shown by lower mRNA abundance of the tight junction 
proteins OCLN and ZO-1 and reduced mucosa sIgA, as well as activation of an immune 
response, as evidenced by increases in both localized and systemic IL-8 production. 
Overall, inclusion of DFM2 in nursery pig diets may be a useful tool to help alleviate PWD 
induced by an ETEC. The somewhat promising results of the DFM2 product indicates a 
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Table 3.1. Ingredient and nutrient composition of the experimental diets (as-fed basis, %) 
Item Control Control+DFM11 Control+DFM22 
Ingredient    
 Corn 58.07 58.04 58.04 
 Soybean meal 15.00 15.00 15.00 
 Whey powder 9.00 9.00 9.00 
 HP3003 8.50 8.50 8.50 
 Fishmeal 4.00 4.00 4.00 
 Soybean oil 2.00 2.00 2.00 
 Limestone 1.27 1.27 1.27 
 Monocalcium phosphate 0.10 0.10 0.10 
 Salt 0.68 0.67 0.67 
 Vitamin premix4 0.20 0.20 0.20 
 Trace mineral premix5 0.20 0.20 0.20 
 L-Lysine HCl 0.52 0.52 0.52 
 DL-Methionine 0.19 0.19 0.19 
 L-Threonine 0.16 0.16 0.16 
 L-Valine 0.06 0.06 0.06 
 L-Tryptophan 0.03 0.03 0.03 
 Phytase6 0.02 0.02 0.02 
 DFM1 -- 0.03 -- 
 DFM2 -- -- 0.03 
Calculated nutrient levels7    
 ME, kcal/kg 3,407 3,407 3,407 
 NE, kcal/kg 2,559 2,559 2,559 
 Crude protein 20.34 20.34 20.34 
 Ether extract 4.92 4.92 4.92 
 Total P 0.53 0.53 0.53 
 STTD P 0.43 0.43 0.43 
 Calcium 0.85 0.85 0.85 
 SID Lys 1.40 1.40 1.40 
 SID Met + Cys 0.77 0.77 0.77 
 SID Thr 0.83 0.83 0.83 
 SID Trp 0.24 0.24 0.24 
Analyzed nutrient levels    
 Dry matter 85.52 85.63 85.45 
 GE, kcal/kg 4,329 4,338 4,321 
 Crude protein 21.51 22.32 21.68 
 aEE8 5.69 5.56 5.82 
1Direct-fed microbial 1 (DFM1) = Three strains of Bacillus amyloliquefaciens; 7.5   105 
cfu/g of feed, Danisco Animal Nutrition, Marlborough, UK. 
2Direct-fed microbial 2 (DFM2) = Two strains of Bacillus amyloliquefaciens and one 





3Enzymatically-treated soybean meal; Hamlet Protein, Findlay, OH 
4Provided per kg of diet: 7,656 IU vitamin A, 875 IU vitamin D, 63 IU vitamin E, 4 mg 
vitamin K, 70 mg niacin, 34 mg pantothenic acid, 14 mg riboflavin, and 0.06 mg vitamin 
B12. 
5Provided per kg of diet: 165 mg Zn (zinc sulfate), 165 mg Fe (iron sulfate), 39 mg Mn 
(manganese sulfate), 17 mg Cu (copper sulfate), 0.3 mg I (calcium iodate), and 0.3 mg Se 
(sodium selenite). 
62,000 FTU/kg of feed provided 0.109% available P; AxtraPhy, Danisco Animal 
Nutrition, Marlborough, UK. 
7STTD = standardized total tract digestible; SID = standardized ileal digestible. 




Table 3.2. Primer sequences used for quantitative PCR  





TNFα F: CACCACGCTCTTCTGCCTAC 132 X57321 
 R: ACGGGCTTATCTGAGGTTTGAGACG   
CLDN1 F: GATTTACTCCTACGCTGGTGAC 199 AJ318102  
 R: CACAAAGATGGCTATTAGTCCC   
CLDN3 F: TTGCATCCGAGACCAGTCC 85 NM_001160075 
 R: AGCTGGGGAGGGTGACA   
OCLN F: AACTCCCGTCAGCAGATCC 95 NM_001163647 
 R: ATCAGTGGAAGTTCCTGAACCA   
ZO-1 F: CTCTTGGCTTGCTATTCG 197 XM_003353439 
 R: AGTCTTCCCTGCTCTTGC   
TLR4 F: CAGATAAGCGAGGCCGTCATT  113 AB232527  
 R: TTGCAGCCCACAAAAAGCA   
CD14 F: CCTCAGACTCCGTAATGTG  180 AB267810  
 R: CCGGGATTGTCAGATAGG   
RPL19 F: AACTCCCGTCAGCAGATCC 147 AF435591  
  R: AGTACCCTTCCGCTTACCG  
 
1TNFα = tumor necrosis factor alpha; CLDN1 = claudin-1; CLDN3 = claudin-3; 
OCLN = occludin; ZO-1 = zonula occludens-1; TLR4 = toll-like receptor 4; CD14 = 












NC PC DFM1 DFM2 
BW, kg       
dpi -7 6.59 6.59 6.34 6.17 0.17 0.785 
dpi 0 6.88 6.83 6.73 6.80 0.17 0.990 
dpi 10 10.78a 9.22b 8.55b 9.17b 0.17 <.0001 
dpi -7 to 0       
ADG, kg 0.04 0.03 0.05 0.09 0.01 0.466 
ADFI, kg 0.08 0.09 0.08 0.11 0.01 0.859 
G:F2 0.45b 0.34b 0.67ab 0.79a 0.06 0.035 
dpi 1 to 10       
ADG, kg 0.39a 0.19b 0.15b 0.22b 0.01 <.0001 
ADFI, kg 0.49a 0.33b 0.19b 0.33b 0.01 <.0001 
G:F 0.81 0.54 0.51 0.65 0.06 0.203 
a,bMeans with differing superscripts indicate a significant (P < 0.05) difference.  
1NC = non-challenged control (n=10); PC = positive challenged control (n=9); DFM1 = 
PC + DFM1 (n=8; 3 strains of Bacillus amyloliquefaciens; 7.5   105 cfu/g of feed); 
DFM2 = PC + DFM2 (n=7; 2 strains of Bacillus amyloliquefaciens and 1 strain of 
Bacillus subtilis; 1.5   105 cfu/g of feed). Supplementation rates were based on 
manufacturer’s recommendations (Danisco Animal Nutrition, Marlborough, UK). 
2Gain:feed ratio. Interpretation of G:F should be cautious because values less than -1.4 
were removed from analysis (2 numbers pre-challenge from PC and DFM1). 
Additionally, 3 pigs in PC had G:F ranging from -0.47 to -0.07 and 1 pig from DFM1 
had a G:F = -0.56. Five pigs with G:F > 1 from both DFM treatments during dpi -7 to 0 






Table 3.4. Effect of treatment on mucosa cytokines2, disaccharidase activity3, and 




NC PC DFM1 DFM2 
IFN 7.04 7.96 5.07 7.47 1.57 0.521 
IL-1rα 20.56 24.06 19.21 16.48 3.69 0.828 
IL-1α 1.66 1.88 2.11 1.70 0.27 0.421 
IL-1ß 8.30 9.59 12.08 7.55 1.59 0.397 
IL-2 0.49 0.69 0.57 0.52 0.11 0.465 
IL-4 0.79 0.48 0.58 0.48 0.17 0.508 
IL-6 0.35 0.57 0.86 0.24 0.20 0.212 
IL-8 240.20b 343.06a 288.07ab 283.42ab 29.13 0.011 
IL-10 0.30 0.25 0.27 0.25 0.04 0.302 
IL-12 3.06 3.81 3.14 4.35 0.44 0.214 
IL-18 220.69 227.45 223.82 229.00 27.64 0.854 
Lactase 0.07 0.11 0.03 0.13 0.05 0.511 
Sucrase 1.81c 4.49a 2.56b 4.72a 0.58 0.003 
Maltase 7.39c 14.16ab 9.61bc 20.91a 2.64 0.004 
sIgA 2.50a 1.11b 1.37b 0.95b 0.33 0.011 
a,b,cMeans with differing superscripts indicate a significant (P < 0.05) difference.  
1NC = non-challenged control (n=10); PC = positive challenged control (n=9); DFM1 
= PC + DFM1 (n=8; 3 strains of Bacillus amyloliquefaciens; 7.5   105 cfu/g of feed); 
DFM2 = PC + DFM2 (n=7; 2 strains of Bacillus amyloliquefaciens and 1 strain of 
Bacillus subtilis; 1.5   105 cfu/g of feed). Supplementation rates were based on 
manufacturer’s recommendations (Danisco Animal Nutrition, Marlborough, UK). 
2ng/g of mucosa. 
3U/minute/g of protein. 
4g/mg of protein. 




Table 3.5. Effect of treatment on relative ileal gene mRNA abundance in weaned pigs 








NC PC DFM1 DFM2 
CLDN1 1.15 0.59 0.75 1.12 0.21 0.145 
CLDN3 0.98 0.64 0.65 0.95 0.34 0.332 
OCLN 1.15a 0.48b 0.54b 0.69ab 0.38 0.045 
ZO-1 1.05a 0.56b 0.67b 1.05a 0.10 0.001 
TNFα 1.01 1.84 1.56 2.30 0.37 0.087 
CD14 1.09b 1.52b 1.89ab 2.60a 0.34 0.019 
TLR4 0.88 0.59 0.68 0.95 0.14 0.145 
a,bMeans with differing superscripts indicate a significant (P < 0.05) difference.  
1NC = non-challenged control (n=10); PC = positive challenged control (n=10); DFM1 
= PC + DFM1 (n=8; 3 strains of Bacillus amyloliquefaciens; 7.5   105 cfu/g of feed); 
DFM2 = PC + DFM2 (n=8; 2 strains of Bacillus amyloliquefaciens and 1 strain of 
Bacillus subtilis; 1.5   105 cfu/g of feed). Supplementation rates were based on 
manufacturer’s recommendations (Danisco Animal Nutrition, Marlborough, UK). 
2TNFα: tumor necrosis factor alpha; CLDN1: claudin-1; CLDN3: claudin-3; OCLN: 






Table 3.6. Effect of treatment on ileal morphology and E. coli attachment in weaned pigs 





NC PC DFM1 DFM2 
Villus height, µm 344.41a 253.82b 206.92c 256.05b 14.56 <.0001 
Crypt depth, µm 199.43 177.95 160.44 172.83 10.53 0.074 
VH:CD2 1.74a 1.48ab 1.29b 1.54ab 0.11 0.046 
Attachment, %  0.00 14.80 33.33 0.00 5.72 0.102 
a,b,cMeans with differing superscripts indicate a significant (P < 0.05) difference.  
1NC = non-challenged control (n=10); PC = positive challenged control (n=10); 
DFM1 = PC + DFM1 (n=8; 3 strains of Bacillus amyloliquefaciens; 7.5   105 cfu/g of 
feed); DFM2 = PC + DFM2 (n=8; 2 strains of Bacillus amyloliquefaciens and 1 strain 
of Bacillus subtilis; 1.5   105 cfu/g of feed). Supplementation rates were based on 
manufacturer’s recommendations (Danisco Animal Nutrition, Marlborough, UK). 







Figure 3.1. Effects of treatment on the daily fecal score of pigs challenged with F18 
ETEC. NC = non-challenged control (n=10); PC = positive challenged control (n=9); 
DFM1 = PC + DFM1 (n=8; 3 strains of Bacillus amyloliquefaciens; 7.5   105 cfu/g of 
feed); DFM2 = PC + DFM2 (n=7; 2 strains of Bacillus amyloliquefaciens and 1 strain of 
Bacillus subtilis; 1.5   105 cfu/g of feed). Supplementation rates were based on 
manufacturer’s recommendations (Danisco Animal Nutrition, Marlborough, UK). P (NC 



























Figure 3.2. Effects of treatment on E. coli shedding score of pigs challenged with F18 
ETEC. NC = non-challenged control (n=10); PC = positive challenged control (n=9); 
DFM1 = PC + DFM1 (n=8; 3 strains of Bacillus amyloliquefaciens; 7.5   105 cfu/g of 
feed); DFM2 = PC + DFM2 (n=7; 2 strains of Bacillus amyloliquefaciens and 1 strain of 
Bacillus subtilis; 1.5   105 cfu/g of feed). Supplementation rates were based on 
manufacturer’s recommendations (Danisco Animal Nutrition, Marlborough, UK). P (NC 
vs. PC; overall period) <.0001, P (PC vs. DFM1; overall period) > 0.10, P (PC vs. 


























Figure 3.3. Effects of treatment on daily rectal temperature of pigs challenged with F18 
ETEC. NC = non-challenged control (n=10); PC = positive challenged control (n=9); 
DFM1 = PC + DFM1 (n=8; 3 strains of Bacillus amyloliquefaciens; 7.5   105 cfu/g of 
feed); DFM2 = PC + DFM2 (n=7; 2 strains of Bacillus amyloliquefaciens and 1 strain of 
Bacillus subtilis; 1.5   105 cfu/g of feed). Supplementation rates were based on 
manufacturer’s recommendations (Danisco Animal Nutrition, Marlborough, UK).  P (NC 
vs. PC; overall period) <.0001, P (PC vs. DFM1; overall period) = 0.962; P (PC vs. 




























Figure 3.4. Effects of treatment on plasma IL-8 of pigs challenged with F18 ETEC. NC = 
non-challenged control (n=10); PC = positive challenged control (n=9); DFM1 = PC + 
DFM1 (n=8; 3 strains of Bacillus amyloliquefaciens; 7.5   105 cfu/g of feed); DFM2 = 
PC + DFM2 (n=7; 2 strains of Bacillus amyloliquefaciens and 1 strain of Bacillus 
subtilis; 1.5   105 cfu/g of feed). Supplementation rates were based on manufacturer’s 
recommendations (Danisco Animal Nutrition, Marlborough, UK). P (NC vs. PC; dpi 1) = 
0.069; P (NC vs. PC; dpi 2) = 0.031; P (PC vs. DFM1, DFM2; overall period) > 0.10; P 






























ALTERATION OF MUCOSA-ASSOCIATED MICROBIOTA BY ETEC 
CHALLENGE IN NURSERY PIGS FED DIRECT-FED MICROBIAL BLENDS 
 
Spenser L. Becker*, Qingyun Li*, Eric R. Burrough†, John F. Patience*, Stephan 
Schmitz-Esser* 
 
*Department of Animal Science, Iowa State University, Ames, 50011, USA 
†Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State 
University, Ames, IA 50011 
 
Abstract 
The objectives of this study were to investigate the impact of an F18 ETEC 
challenge, as well as the potential protective effects of two Bacillus-based DFMs, on 
homeostasis of the mucosa-associated microbiota. Seventy-two weaned piglets (6.4  0.6 
kg BW ~21 d of age) were assigned to one of four treatments: 1) NC: Non-challenged 
(n=10), 2) PC: F18 ETEC challenged (n=10), 3) PC + DFM1 (n=8; 3 strains of Bacillus 
amyloliquefaciens; 7.5  105 cfu/g) or 4) PC+DFM2 (n=8; 2 strains of Bacillus 
amyloliquefaciens and 1 strain of Bacillus subtilis; 1.5  105 cfu/g). Pigs were either sham-
infected with 6 mL sterile PBS or orally inoculated with 6 mL hemolytic F18 ETEC (~1.9 
× 109 cfu/mL) on d 7 post-weaning. All ETEC challenged pigs were confirmed to be 
genetically susceptible to F18 ETEC. Pigs had ad libitum access to feed and water 




mucosa scrapings were collected. The V4 region of the 16S rDNA was amplified and 
sequenced. High-quality reads (total 5,421,869) were selected and clustered into 7,570 
OTUs based on 99% sequence similarity.  
The ETEC challenge disrupted gut microbial homeostasis in pigs by increasing 
Escherichia-Shigella, Chlamydia, and Actinobacillus in the intestinal mucosa (q < 0.05). 
This was accompanied by decreases in beneficial genera, including Streptococcus, 
Prevotella_9, and Veillonella (q < 0.05). The inclusion of Bacillus-based DFMs altered the 
mucosa-associated microbiota to preserve or reestablish homeostasis in the GIT. Greater 
abundance of Prevotella_9 and Veillonella in the colon mucosa was observed in pigs fed 
DFM1 than those fed PC (q < 0.05). Supplementation of DFM2 increased Streptococcus 
and reduced Escherichia-Shigella, Chlamydia, Helicobacter (OTU 140), and 
Fusobacterium in the intestinal mucosa compared with PC (q < 0.05). This demonstrates 
the ability of DFM2 to reduce pathogenic bacteria load. These results suggest that an ETEC 
challenge negatively alters gastrointestinal function by inducing microbial dysbiosis 
through the increase in potentially pathogenic bacteria and reduction in beneficial bacteria. 
Supplementation of Bacillus-based DFMs appeared to have altered the mucosa-associated 
microbiota to preserve or reestablish homeostasis in the GIT and may be a beneficial 
feeding strategy used to alleviate the effects of an ETEC challenge in weaned pigs.  
 
Introduction 
 Enterotoxigenic E. coli (ETEC) in weaned pigs causes the breakdown of 
gastrointestinal tract functions, resulting in decreased feed intake and growth, as well as 




developed with the objective to prevent or mitigate the negative impacts of ETEC 
infections, the swine industry worldwide continues to experience substantial economic 
losses due to this pathogen. Concerns regarding antimicrobial resistance has led to reduced 
antibiotic use in swine production; thus, alternative products to mitigate ETEC infections 
in nursery pigs are needed. Direct-fed microbial blends (DFM) are products that contain 
live microorganisms, typically strains of Bacillus, Lactobacillus, Bifidobacterium, and/or 
Enterococcus. Several methods by which DFMs beneficially affect the host have been 
proposed, including production of antimicrobial compounds and enzymes, enhanced 
nutrient digestibility, improvements in intestinal barrier integrity, modulation of immune 
response, promotion of beneficial bacterial growth, and competitive exclusion of 
pathogenic bacteria (Meng et al., 2010; Hu et al., 2014; Lee et al., 2014; Yirga et al., 2015).  
Healthy microbial populations in the gastrointestinal tract (GIT) contribute to 
enhanced performance and immunity. Lactobacillus is a highly abundant, beneficial 
bacterial group found in the GIT of pigs. After weaning, alterations in these mucosa-
associated beneficial bacteria occur, allowing pathogens to colonize and proliferate, which 
negatively impacts intestinal health and subsequent growth performance; however, a 
greater understanding of microbiota changes following a direct ETEC challenge in weaned 
pigs is needed. DFMs are suggested to balance the GIT microbial population dynamics in 
order to create a more beneficial microbial population. Previous results demonstrated that 
an ETEC challenge reduced growth performance of weaned pigs as a result of increased 
diarrhea, reduced rectal temperature, secretory immunoglobulin a (sIgA) and tight junction 
protein gene transcription (Becker et al., 2019). The supplementation of a Bacillus-based 




shedding; thus, a better understanding of how the DFM is modifying these responses to an 
ETEC challenge is warranted. The continued development of new technologies, such as 
16S rRNA gene sequencing, offers means to investigate microbial communities and their 
interactions with the host immune system, genetics, environment, and diet (Holman et al., 
2017; Pollock et al., 2018). 
Therefore, the objectives of this study were to investigate the impact of an F18 
ETEC challenge, as well as the potential protective effects of two Bacillus-based DFMs, 
on homeostasis of the mucosa-associated microbiota.  
Materials and methods 
 All experimental procedures adhered to guidelines for the ethical and humane use 
of animals for research and were approved by the Iowa State University Institutional 
Animal Care and Use Committee (IACUC #8-17-8576-S). 
Animals, diets, and sampling 
 Seventy-two newly weaned pigs (6.4  0.6 kg BW; ~21d of age; L337   
Camborough, PIC, Hendersonville, TN) were randomly assigned to 1 of 4 dietary 
treatments: a non-challenged control (NC; n = 10), an ETEC challenged positive control 
(PC; n = 10), and PC + DFM1 (3 strains of Bacillus amyloliquefaciens; DFM1; n = 8), or 
PC + DFM2 (2 strains of Bacillus amyloliquefaciens and 1 strain of Bacillus subtilis; 
DFM2; n = 8). DFM1 and DFM2 were included at 0.03% of the diet to achieve a final dose 
of 7.5  105 cfu/g of feed and 1.5  105 cfu/g of feed, respectively (Danisco Animal 
Nutrition, Marlborough, UK). The control diet was primarily based on corn and soybean 
meal with 9.0% whey powder and 8.5% enzymatically treated soybean meal (Table 4.1). 




(NRC, 2012) and did not contain antibiotics or pharmaceutical levels of copper or zinc. 
Pigs were housed one barrow and one gilt per pen and had free access to feed and water 
during the 17-d trial. The sows and piglets used in this experiment had not been vaccinated 
against E. coli. 
 Prior to ETEC inoculation, all challenged pigs were determined via Sanger DNA 
sequencing of the α (1,2) fucosyltransferase-1 (FUT1) gene to be genetically susceptible 
to F18 ETEC (Frydendahl et al., 2003). On day 7 post-weaning, pigs were orally gavaged 
with 6 mL of sterile PBS or freshly grown F18 ETEC inoculum (1.9 × 109 cfu/mL). A 
fluoroquinolone-resistant hemolytic E. coli isolate that had an enrofloxacin minimal 
inhibitory concentration (MIC) > 2 g/mL was used to prepare the bacterial inoculum at 
the Iowa State University Veterinary Diagnostic Lab (Ames, IA).  
 On day 17, one pig per pen was euthanized via captive bolt stunning followed by 
exsanguination. Post-euthanasia, the abdomen was opened and a segment of ileum 30 cm 
from the ileocecal junction and the apex of the spiral colon were removed, carefully drained 
of digesta, rinsed with ice-cold PBS, and immediately snap frozen in liquid N. Tissue 
samples were stored at -80°C pending analysis. 
DNA extraction 
Total genomic DNA was extracted from ileal and colonic mucosa scrapings (250 
mg) using Dneasy PowerLyzer PowerSoil kit (Qiagen, Germantown, MD) according to the 
manufacturer’s instructions. Genomic DNA concentration and purity were measured using 
a ND-1000 spectrophotometer (NanoDrop Technologies, Rockland, DE). All samples had 





Illumina MiSeq sequencing 
A PCR-amplified 16S rRNA sequencing of 68 pig intestinal mucosa samples was 
conducted using the 16S rRNA gene Illumina Amplicon protocol designed to amplify 
bacteria and archaea (The Earth Microbiome Project; http://www.earthmicrobiome.org/) at 
the Iowa State University DNA Facility (Ames, IA). Briefly, genomic DNA from samples 
was amplified using Platinum™ Taq DNA Polymerase (Thermo Fisher Scientific, 
Waltham, MA) with one replicate per sample. Universal 16S rRNA bacterial primers [515F 
(5′-GTGYCAGCMGCCGCGGTAA-3′; Parada et al., 2016), and 806R (5′-
GGACTACNVGGGTWTCTAAT-3′; Apprill et al., 2015)] for the variable region V4 were 
utilized during the sequencing procedure as previously described (Kozich et al., 2013). All 
the samples underwent PCR with an initial denaturation step at 94°C for 3 min, followed 
by 35 PCR cycles (45 s at 94°C, 20 s at 50°C, and 90 s at 72°C), and finished with a 10 
min extension at 72°C. All the PCR products then were purified with the QIAquick 96 PCR 
Purification Kit (Qiagen Sciences Inc, Germantown, MD) according to the manufacturer’s 
recommendations. PCR bar-coded amplicons were mixed at equal molar ratios and used 
for Illumina MiSeq paired-end sequencing with 150 bp read length and cluster generation 
with 10% PhiX control DNA on an Illumina MiSeq platform (Illumina Inc., San Diego, 
CA). After sequencing, corresponding overlapping paired-end reads were stitched to obtain 
a final amplicon size of approximately 255 bp.  
Quality filtering and sequence analysis 
Samples that failed to generate enough PCR products and contained very low 
numbers of sequencing reads were removed. Raw sequence data in fastq format were 




paired-end reads were combined into contigs and were screened for quality with the 
“screen.seqs” command excluding sequences with any ambiguities. The number of 
homopolymers was set to eight. Sequencing error was reduced by pre-clustering sequences 
with up to 2 bp differences using the “pre.cluster” command. Using the “cluster.split” 
command, sequences were then clustered into operational taxonomic units (OTU) with a 
99% similarity cutoff (0.01 distance) based on the distance matrix generated by default. 
Consensus taxonomy for OTUs was assigned using the “classify.otu” command using the 
SILVA SSU reference database (version 132, Pruesse et al., 2007). Relative abundances 
were calculated for the top 25 OTUs across both intestinal locations. 
Statistical analysis 
Absolute abundances of assigned OTUs were analyzed using a negative binomial 
distribution in GLIMMIX of SAS (9.4, Cary, NC). Data were offset by the total library 
count for each sample. Treatment was a fixed effect and pen was the experimental unit. 
Pre-planned contrasts were performed using the ESTIMATE statement to evaluate the 
effects of the ETEC challenge (NC vs. PC) and dietary treatment (PC vs. DFM1, DFM2). 
Assigned P values were corrected for multiple comparisons using the “Qvalue” package 
of R statistical software. Differences were considered significant if q was ≤ 0.05 and a 
tendency if q was > 0.05 and ≤ 0.10.  
 
Results 
There were 68 mucosa samples, 34 each from the ileum and the colon. A total of 
5,421,869 high-quality reads were obtained after size filtering and quality control, with an 




similarity, 7,570 OTUs (> 10 sequences per OTU) were classified. At the genus level, 
Helicobacter dominated the mucosal microbiota (17.49%; Table 4.2), followed by 
Lactobacillus (7.31%) and Escherichia-Shigella (5.28%). 
Microbiota in the ileal mucosa 
At the genus level, the PC increased the abundances of Escherichia-Shigella, 
Turicibacter, and Actinobacillus (OTU 24; q ≤ 0.036; Table 4.3), and tended to decrease 
Acidaminococcus compared with NC (q = 0.068). Greater abundances of Streptococcus, 
and Intestinibacter were observed in the NC compared with PC (q ≤ 0.036). There were 
no differences in absolute abundances between NC and PC for Helicobacter, Enterococcus, 
Lactobacillus, Fusobacterium, or Actinobacillus (OTU 47; q > 0.10). Compared with PC, 
DFM1 increased Helicobacter and Acidaminococcus (q ≤ 0.034) and tended to decrease 
Lactobacillus (q = 0.052) and increase Actinobacillus (OTU 47; q = 0.066). The abundance 
of Escherichia-Shigella, Streptococcus, Enterococcus, and Fusobacterium did not differ 
between PC and DFM1 (q > 0.10). DFM1 or DFM2 did not differ from PC in the 
abundances of Turicibacter, Actinobacillus (OTU 24) or Intestnibacter (q > 0.10). DFM2 
significantly reduced the abundances of Escherichia-Shigella, Enterococcus, 
Lactobacillus, and Fusobacterium compared with PC (q ≤ 0.034). The abundance of 
Helicobacter, Turicibacter, Actinobacillus (OTU 24), Acidaminococcus, and 
Intestinibacter did not differ between PC and DFM2 (q > 0.10).  
Microbiota in the colon mucosa 
 At the genus level, Prevotella_9 was reduced in PC compared with NC (q = 0.003; 
Table 4.4). The PC increased Chlamydia, Romboustia and Clostridium_sensu_stricto_1 




compared with NC (q  = 0.066). PC was not different from NC in Escherichia-Shigella, 
Anaerovibrio, Methanobrevibacter, Desulfovibrio, Helicobacter, and Bacteroides 
abundance (q > 0.10). Compared with PC, pigs receiving DFM1 did not differ in the 
abundance of Escherichia-Shigella, Chlamydia, Romboutsia, 
Clostridium_sensu_stricto_1, and Helicobacter (q > 0.10). Prevotella_9 and Veillonella, 
abundances were increased in DFM1 (q ≤ 0.037) compared with PC, while Anaerovibrio, 
Desulfovibrio, Bacteroides and Methanobrevibacter abundances were decreased in pigs 
fed DFM1 (q ≤ 0.047). DFM2 had decreased abundance of Escherichia-Shigella, 
Chlamydia, and Helicobacter compared with PC (q ≤ 0.017).  
Discussion 
Pathogenic bacterial infections can cause proliferation of other harmful bacteria or 
opportunistic pathogens, resulting in dysbiosis of the intestinal microbiota (Gresse et al, 
2017; Pollock et al., 2018). Our previous findings revealed that an ETEC challenge reduced 
growth performance of nursery pigs; however, pigs fed a Bacillus-based DFM had 
improved intestinal barrier integrity. To enhance our understanding of how an F18 ETEC 
challenge modifies the pig’s gastrointestinal function and how DFMs alter their response 
to a pathogenic challenge, high-throughput 16S rRNA gene sequencing technology was 
used. Utilization of this technology provides great advantages in analyzing a broad range 
of phylotypes at the genus level; however, the species-level classification may be 
insufficient due to the relatively short amplicon length. Furthermore, the absence of 
closely-related characterized reference strains makes it challenging to classify swine-




well as the potential protective effects of Bacillus-based DFMs, on microbial homeostasis 
in the gastrointestinal tract.  
The detected abundances of Bacillus genus in the mucosa were low regardless of 
treatment or GIT location, which is in agreement with recent research utilizing 16S rRNA 
gene sequencing on fecal and intestinal samples of pigs fed Bacillus-based products 
(Poulsen et al., 2018). This could be attributed to a variety of factors, including sample 
type, primer bias, and/or bias in the DNA extraction method due to the resilient spore 
structure. It has been shown that Bacillus spores have the ability to germinate in significant 
numbers; however, this does not correlate to colonization in the mucus layer. Previous 
work has demonstrated a lack of or temporary colonization of Bacillus spp. in the GIT 
(Casula and Cutting, 2002; Leser et al., 2007; Bernardeau et al., 2017).  
Despite the evident lack of Bacillus proliferation, supplementation of the DFMs did 
appear to have an effect on the mucosal microbiota. As expected, the ETEC challenge 
increased the abundance of Escherichia-Shigella in the ileal mucosa compared with NC; 
however, differences between pathogenic and indigenous strains of Escherichia-Shigella 
cannot be distinguished. These results agree with the elevated fecal E. coli shedding and 
increased fecal scores previously reported (Becker et al., 2019). DFM2 reduced abundance 
of Escherichia-Shigella compared with PC in both the ileum and colon mucosa, which 
aligns with previous observations in these pigs (Becker et al., 2019) and corresponds with 
previous studies in which Bacillus-based DFMs were fed to nursery pigs (Hu et al., 2013; 
Zhang et al., 2017).  
Prevotella_9 and Streptococcus are highly abundant bacteria in the gastrointestinal 




and Streptococcus were reduced in PC compared to NC, representing beneficial bacteria 
negatively altered by ETEC challenge. Streptococcus spp. contribute to lactic acid 
production and are often used in DFM products. DFM2 increased the abundance of 
Streptococcus in the ileum, possibly indicating a beneficial alteration of the mucosal 
microbiota. Though certain species of Streptococcus are pathogenic in swine, species 
cannot be differentiated using the current methodology. Prevotella produce short-chain 
fatty acids (SCFA) by metabolizing non-starch polysaccharides derived from plants 
(Ivarrson et al., 2014). These bacteria have also been shown to produce exogenous 
enzymes, such as mannanase, -glucanase, and xylanase, which aid in the degradation of 
plant cell wall polysaccharides (Flint and Bayer, 2008). Prevotella abundance has also been 
positively correlated with secretory IgA concentrations in the intestinal mucosa and 
increased animal growth (Mach et al., 2015). Pigs fed DFM1 had increased Prevotella_9 
in the colon, suggesting the ability of DFM1 to promote beneficial bacterial growth. DFM1 
also increased the abundance of Veillonella compared with PC, while PC tended to have 
Veillonella compared with NC. These indigenous bacteria have the ability to produce acetic 
and propionic acids from lactic acid. High concentrations of these SCFAs can then inhibit 
pathogenic bacteria growth (Hinton et al., 1991; Hinton and Hume 1997).  
Research has shown that Fusobacterium abundance is increased during enteric 
infections in pigs, including porcine epidemic diarrhea virus (Koh et al., 2015) and swine 
dysentery (Burrough et al., 2017), as well as in piglets with non-specific diarrhea (Dou et 
al., 2017; Yang et al, 2017). The reduced Fusobacterium in the ileal mucosa of DFM2 pigs 
compared with PC indicates a positive modulation of the microbial population. DFM2 




the decrease in the abundance of Helicobacter (OTU 140); however, DFM1 increased 
Helicobacter (OTU 11) in the ileum. Helicobacter is a potentially pathogenic bacterial 
genus that is known to associate with the mucosal microbiota population and is highly 
abundant in weaned pigs (Mann et al., 2014; Adhikari et al., 2019); however, the function 
of these particular Helicobacter OTUs in pigs remains unknown.  
The abundance of Chlamydia, a known pathogen, was increased in the colon 
mucosa of PC compared with NC, and DFM2 had reduced abundance of Chlamydia 
compared with PC. Chlamydia are obligate intracellular bacteria, meaning they need to live 
within epithelial cells to survive (Rank and Yeruva, 2014). The increase in mucosal 
Chlamydia in PC and DFM1 pigs challenged treatments may be a result of impaired 
intestinal integrity previously observed in these pigs (Becker et al., 2019). These results 
denote an ETEC-induced disruption of microbial homeostasis in pigs, which appeared to 
be attenuated by DFM2. Actinobacillus spp. are also especially pathogenic bacteria in 
swine (Fairbrother and Gyles, 2012). In the ileum, abundance of Actinobacillus (OTU 24) 
increased in PC compared with NC, thus representing another potential pathogenic bacteria 
impacted by the ETEC challenge.  
Conclusions 
In this study, an ETEC challenge disrupted gut microbial homeostasis in pigs by 
increasing the abundance of potentially pathogenic bacteria in the ileal and colonic mucosa, 
including Escherichia-Shigella, and potentially Chlamydia, and Actinobacillus. This was 
accompanied by decreases in beneficial genera, including Streptococcus, Prevotella_9, and 
Veillonella in the intestinal mucosa. The inclusion of Bacillus-based DFMs altered the 




abundance of Prevotella_9 and Veillonella in the colon mucosa was observed in pigs fed 
DFM1 than those fed PC. This indicates DFM1 is effective in elevating the abundance of 
potentially beneficial bacteria in the intestine, though DFM1 also increased Helicobacter 
(OTU 11) compared with PC. Supplementation of DFM2 increased Streptococcus and 
reduced Escherichia-Shigella, Chlamydia, Helicobacter (OTU 140), and Fusobacterium 
in the intestinal mucosa compared with PC. This demonstrates the ability of DFM2 to 
reduced pathogenic bacteria load. Taken together with results from Becker et al. (2019), 
these findings suggest that the ETEC challenge negatively altered gastrointestinal function 
by inducing microbial dysbiosis through the increase in potentially pathogenic bacteria and 
the reduction of beneficial bacteria in the mucosa. The supplementation of a DFM 
containing 2 strains of Bacillus amyloliquefaciens and 1 strain of Bacillus subtilis may be 
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Table 4.1. Ingredient and nutrient composition of the experimental diets (as-fed basis, %) 
Item Control Control+DFM11 Control+DFM22 
Ingredient    
 Corn 58.07 58.04 58.04 
 Soybean meal 15.00 15.00 15.00 
 Whey powder 9.00 9.00 9.00 
 HP3003 8.50 8.50 8.50 
 Fishmeal 4.00 4.00 4.00 
 Soybean oil 2.00 2.00 2.00 
 Limestone 1.27 1.27 1.27 
 Monocalcium phosphate 0.10 0.10 0.10 
 Salt 0.68 0.67 0.67 
 Vitamin premix4 0.20 0.20 0.20 
 Trace mineral premix5 0.20 0.20 0.20 
 L-Lysine HCl 0.52 0.52 0.52 
 DL-Methionine 0.19 0.19 0.19 
 L-Threonine 0.16 0.16 0.16 
 L-Valine 0.06 0.06 0.06 
 L-Tryptophan 0.03 0.03 0.03 
 Phytase6 0.02 0.02 0.02 
 DFM1 -- 0.03 -- 
 DFM2 -- -- 0.03 
Calculated nutrient levels7    
 ME, kcal/kg 3,407 3,407 3,407 
 NE, kcal/kg 2,559 2,559 2,559 
 Crude protein 20.34 20.34 20.34 
 Ether extract 4.92 4.92 4.92 
 Total P 0.53 0.53 0.53 
 STTD P 0.43 0.43 0.43 
 Calcium 0.85 0.85 0.85 
 SID Lys 1.40 1.40 1.40 
 SID Met + Cys 0.77 0.77 0.77 
 SID Thr 0.83 0.83 0.83 
 SID Trp 0.24 0.24 0.24 
Analyzed nutrient levels    
 Dry matter 85.52 85.63 85.45 
 GE, kcal/kg 4,329 4,338 4,321 
 Crude protein 21.51 22.32 21.68 
 aEE8 5.69 5.56 5.82 
1Direct-fed microbial 1 (DFM1) = Three strains of Bacillus amyloliquefaciens; 7.5   105 
cfu/g of feed, Danisco Animal Nutrition, Marlborough, UK. 
2Direct-fed microbial 2 (DFM2) = Two strains of Bacillus amyloliquefaciens and one 





3Enzymatically-treated soybean meal; Hamlet Protein, Findlay, OH 
4Provided per kg of diet: 7,656 IU vitamin A, 875 IU vitamin D, 63 IU vitamin E, 4 mg 
vitamin K, 70 mg niacin, 34 mg pantothenic acid, 14 mg riboflavin, and 0.06 mg vitamin 
B12. 
5Provided per kg of diet: 165 mg Zn (zinc sulfate), 165 mg Fe (iron sulfate), 39 mg Mn 
(manganese sulfate), 17 mg Cu (copper sulfate), 0.3 mg I (calcium iodate), and 0.3 mg Se 
(sodium selenite). 
62,000 FTU/kg of feed provided 0.109% available P; AxtraPhy, Danisco Animal 
Nutrition, Marlborough, UK. 
7STTD = standardized total tract digestible; SID = standardized ileal digestible. 










Phylum Family Genus 
Relative 
abundance (%) 
1 948550 Epsilonbacteraeota  Helicobacteraceae  Helicobacter  17.49 
2 396193 Firmicutes  Lactobacillaceae  Lactobacillus  7.31 
3 286215 Proteobacteria  Enterobacteriaceae  Escherichia-Shigella  5.28 
4 122143 Firmicutes  Clostridiaceae_1  Clostridium_sensu_stricto_1  2.25 
5 108787 Firmicutes  Streptococcaceae  Streptococcus  2.01 
6 65624 Firmicutes  Lactobacillaceae  Lactobacillus  1.21 
7 61776 Firmicutes  Lactobacillaceae  Lactobacillus  1.14 
8 59116 Firmicutes  Veillonellaceae  Megasphaera  1.09 
9 57376 Epsilonbacteraeota  Campylobacteraceae  Campylobacter  1.06 
10 57250 Chlamydiae  Chlamydiaceae  Chlamydia  1.06 
11 54946 Epsilonbacteraeota  Helicobacteraceae  Helicobacter  1.01 
12 52144 Actinobacteria  Bifidobacteriaceae  Bifidobacterium  0.96 
13 51472 Firmicutes  Ruminococcaceae  Ruminiclostridium_5  0.95 
14 47779 Bacteroidetes  Prevotellaceae  Prevotella_9  0.88 
15 46607 Proteobacteria  Pasteurellaceae  Actinobacillus  0.86 
16 42735 Firmicutes  Erysipelotrichaceae  Turicibacter  0.79 
17 40855 Firmicutes  Lactobacillaceae  Lactobacillus  0.75 
18 38051 Firmicutes  Ruminococcaceae  Ruminococcaceae_UCG-008  0.70 
19 37300 Proteobacteria  Pasteurellaceae  Pasteurellaceae_unclassified  0.69 
20 36357 Firmicutes  Peptostreptococcaceae  Terrisporobacter  0.67 
21 34886 Firmicutes  Streptococcaceae  Streptococcus  0.64 
22 33389 Firmicutes  Ruminococcaceae  Subdoligranulum  0.62 
23 29873 Firmicutes  Lactobacillaceae  Lactobacillus  0.55 
24 29449 Proteobacteria  Pasteurellaceae  Actinobacillus  0.54 








Table 4.3. Effects of treatment on microbial abundance in the ileal mucosa, % 
OTU Genus Treatment
1 
SEM q – value contrasts
2 
NC PC DFM1 DFM2 1 2 3 
3 Escherichia-Shigella 0.322 14.781 22.191 0.207 2.881 0.004 0.929 0.004 
11 Helicobacter 0.001 0.003 0.844 0.003 0.045 0.726 0.004 1.000 
16 Turicibacter 0.108 1.446 0.642 1.223 0.105 0.036 0.695 1.000 
21 Streptococcus 1.627 0.017 0.027 0.624 0.126 0.004 0.929 0.029 
24 Actinobacillus 0.008 3.302 0.270 0.344 0.416 0.007 0.432 0.503 
30 Enterococcus 0.173 0.902 0.421 0.006 0.079 0.500 0.860 0.007 
34 Lactobacillus 0.834 1.370 0.058 0.011 0.115 0.911 0.052 0.004 
38 Fusobacterium 0.000 0.441 1.174 0.001 0.201 1.000 0.883 0.031 
82 Acidaminococcus 0.030 0.001 0.058 0.006 0.153 0.068 0.034 0.571 
88 Intestinibacter 0.008 0.000 0.001 0.001 0.003 0.036 0.842 0.982 
1NC = non-challenged control (n=10); PC = positive challenged control (n=10); DFM1 = PC + DFM1 (n=8; 3 strains of Bacillus 
amyloliquefaciens; 7.5   105 cfu/g of feed); DFM2 = PC + DFM2 (n=8; 2 strains of Bacillus amyloliquefaciens and 1 strain of 
Bacillus subtilis; 1.5   105 cfu/g of feed). Supplementation rates were based on manufacturer’s recommendations (Danisco Animal 
Nutrition, Marlborough, UK). 







Table 4.4. Effect of treatment on microbial abundance in the colon mucosa, % 
OTU Genus Treatment
1 
SEM q – value contrasts
2 
NC PC DFM1 DFM2 1 2 3 
3 Escherichia-Shigella 3.337 1.529 0.514 0.009 5.853 0.868 0.800 0.008 
10 Chlamydia 0.024 0.298 0.316 0.006 0.028 0.035 0.999 0.003 
26 Romboutsia 0.020 0.418 1.490 0.389 0.338 0.024 0.561 0.999 
37 Prevotella_9 1.241 0.003 0.202 0.012 0.280 0.003 0.037 0.698 
64 Anaerovibrio 0.266 0.267 0.009 0.456 0.040 0.999 0.008 0.891 
77 Veillonella 0.062 0.000 0.639 0.029 0.125 0.066 0.008 0.160 
96 Clostridium_sensu_stricto_1 0.004 0.087 0.123 0.038 0.008 0.028 0.962 0.800 
105 Methanobrevibacter 0.145 0.297 0.000 0.111 0.042 0.960 0.017 0.909 
134 Desulfovibrio 0.044 0.219 0.001 0.183 0.028 0.693 0.017 0.999 
140 Helicobacter 0.052 0.292 0.074 0.002 0.029 0.517 0.695 0.017 
186 Bacteroides 0.058 0.168 0.007 0.024 0.012 0.688 0.047 0.325 
1NC = non-challenged control (n=10); PC = positive challenged control (n=10); DFM1 = PC + DFM1 (n=8; 3 strains of Bacillus 
amyloliquefaciens; 7.5   105 cfu/g of feed); DFM2 = PC + DFM2 (n=8; 2 strains of Bacillus amyloliquefaciens and 1 strain of 
Bacillus subtilis; 1.5   105 cfu/g of feed). Supplementation rates were based on manufacturer’s recommendations (Danisco Animal 
Nutrition, Marlborough, UK). 









Throughout all production stages, pigs are exposed to several stressors and 
pathogenic organisms that reduce growth performance and increase mortality and 
morbidity. Newly weaned pigs are particularly more susceptible to pathogenic infection 
due to their underdeveloped gastrointestinal tract (GIT) and immune system. Post-weaning 
diarrhea (PWD) induced by enterotoxigenic Escherichia coli (ETEC) has been a long-
recognized problem in swine production worldwide that has contributed to significant 
economic losses for producers. Following colonization and proliferation in the GIT, ETEC 
produces one or more enterotoxins that alter water and ion flux in the small intestine, 
resulting in clinical symptoms of diarrhea and dehydration (Sun and Kim, 2017). As pork 
producers continue to limit or remove antibiotics from production practices, there is an 
undoubted need for alternative strategies to prevent or mitigate these production losses. In-
feed supplementation of direct-fed microbials (DFMs) is one such strategy that has been 
proposed to improve intestinal function and health of the weaned pig in order to reduce 
negative impacts on growth performance (Yirga, 2015); however, results in pigs have been 
inconsistent. The objectives of this thesis were to evaluate the potential beneficial effects 
of Bacillus-based DFMs under normal physiological and ETEC challenge conditions and 
to characterize the impact of an ETEC challenge in weaned pigs on growth, intestinal 





Experiment 1 (Chapter 2) evaluated the effects of two novel Bacillus-based direct-
fed microbial blends on nursery pig growth performance in a commercial-like 
environment. The data from this experiment revealed that supplementation of either DFM 
did not impact the growth performance of nursery pigs with in good health. It is also 
hypothesized that the efficacy of the DFM could have been altered by dietary ingredients, 
such as zinc oxide. It is also possible that the response to DFM supplementation would be 
greater in pigs with a poor health status (McEwen and Fedorka-Cray, 2002). Additionally, 
a further understanding of how ETEC is physiologically impacting the pig is necessary in 
order to develop effective feeding strategies. Therefore, the objectives of Experiment 2 
(Chapters 3 and 4) were to investigate the impact of an ETEC challenge on growth 
performance, intestinal barrier function, immune response, and microbial homeostasis of 
weaned pigs while concurrently evaluating the potential protective effects of DFMs. 
In chapter 3, it was found that an ETEC challenge reduced rectal temperature, 
impaired intestinal barrier integrity through alterations in tight junction proteins, increased 
systemic and localize IL-8 production, and reduced ileal mucosal sIgA. This resulted in 
blunted growth performance during the 10-d post-challenge period. Pigs were subjected to 
an extremely severe health challenge, resulting in acute clinical symptoms and high 
mortality outcomes (23%), which is not unusual in ETEC challenged pigs if left untreated 
(Fairbrother and Gyles, 2012). However, pigs appeared to be recovering from infection by 
the end of the challenge period, as evidenced by decreases in ETEC shedding and a lack of 
E. coli attachment to the intestinal epithelial lining. The lack of febrile response in ETEC 
challenged pigs is possibly explained by the reduction in feed intake and dehydration 





DFM1 did not appear to attenuate the impacts of ETEC; however, DFM2 may provide 
some protection to nursery pigs challenged with ETEC by improving ETEC shedding and 
intestinal barrier integrity.  
In chapter 4, an ETEC challenge disrupted microbial homeostasis in the intestinal 
mucosa by increasing the abundance of potentially pathogenic genera in the ileal and 
colonic mucosa, including Escherichia-Shigella, Helicobacter, Fusobacterium, and 
Actinobacillus. This was accompanied by decreases in beneficial bacteria, including 
Lactobacillus, Faecalibacterium, Alloprevotella, and Ruminococcus. The supplementation 
of DFM2 appeared to have altered the mucosa-associated microbiota to preserve or 
reestablish homeostasis in the GIT by reducing pathogenic bacterial load, which may 
explain the improved intestinal barrier integrity observed in chapter 3. 
Recommendations for future research 
 When considering nutritional strategies to aid in the prevention and mitigation of 
post-weaning stressors and infection, Bacillus-based DFMs appear to be a promising 
candidate as a feed additive. Future research evaluating non-antibiotic alternative products 
and their interactions with each other, as well as dietary ingredients, is necessary in order 
to understand their mode of action in the pig. This is especially important when 
characterizing the microbial population in the GIT, as substrate is the major driver of 
population composition. Future research evaluating products in health-challenged 
conditions should consider using a non-challenged control group in order to quantify the 
severity of the challenge. This would also allow differentiation of microbiota changes due 
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